x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Jersey
|
|
98-1029562
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
Large accelerated filer
|
x
|
|
|
|
Accelerated filer
|
¨
|
Non-accelerated filer
|
¨
|
|
|
|
Smaller reporting company
|
¨
|
|
|
|
|
|
Emerging growth company
|
¨
|
Title of each class
|
|
Trading symbol(s)
|
|
Name of each exchange on which registered
|
Ordinary Shares. $0.01 par value per share
|
|
APTV
|
|
New York Stock Exchange
|
|
||
|
|
Page
|
Part I - Financial Information
|
||
Item 1.
|
|
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
Part II - Other Information
|
||
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 6.
|
||
|
|
|
|
||
Exhibits
|
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
|
(in millions, except per share amounts)
|
||||||
Net sales
|
$
|
3,575
|
|
|
$
|
3,630
|
|
Operating expenses:
|
|
|
|
||||
Cost of sales
|
2,962
|
|
|
2,947
|
|
||
Selling, general and administrative
|
256
|
|
|
259
|
|
||
Amortization
|
34
|
|
|
30
|
|
||
Restructuring (Note 7)
|
26
|
|
|
20
|
|
||
Total operating expenses
|
3,278
|
|
|
3,256
|
|
||
Operating income
|
297
|
|
|
374
|
|
||
Interest expense
|
(38
|
)
|
|
(34
|
)
|
||
Other income, net (Note 16)
|
16
|
|
|
30
|
|
||
Income before income taxes and equity income
|
275
|
|
|
370
|
|
||
Income tax expense
|
(33
|
)
|
|
(59
|
)
|
||
Income before equity income
|
242
|
|
|
311
|
|
||
Equity income, net of tax
|
3
|
|
|
5
|
|
||
Net income
|
245
|
|
|
316
|
|
||
Net income attributable to noncontrolling interest
|
5
|
|
|
9
|
|
||
Net income attributable to Aptiv
|
$
|
240
|
|
|
$
|
307
|
|
|
|
|
|
||||
Basic net income per share:
|
|
|
|
||||
Basic net income per share attributable to Aptiv
|
$
|
0.93
|
|
|
$
|
1.16
|
|
Weighted average number of basic shares outstanding
|
259.08
|
|
|
265.69
|
|
||
|
|
|
|
||||
Diluted net income per share:
|
|
|
|
||||
Diluted net income per share attributable to Aptiv
|
$
|
0.92
|
|
|
$
|
1.15
|
|
Weighted average number of diluted shares outstanding
|
259.55
|
|
|
266.44
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Net income
|
$
|
245
|
|
|
$
|
316
|
|
Other comprehensive income:
|
|
|
|
||||
Currency translation adjustments
|
1
|
|
|
61
|
|
||
Net change in unrecognized gain (loss) on derivative instruments, net of tax (Note 14)
|
19
|
|
|
(23
|
)
|
||
Employee benefit plans adjustment, net of tax
|
2
|
|
|
1
|
|
||
Other comprehensive income
|
22
|
|
|
39
|
|
||
Comprehensive income
|
267
|
|
|
355
|
|
||
Comprehensive income attributable to noncontrolling interests
|
6
|
|
|
13
|
|
||
Comprehensive income attributable to Aptiv
|
$
|
261
|
|
|
$
|
342
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
(Unaudited)
|
|
|||||
|
|
|
|
||||
|
(in millions)
|
||||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
321
|
|
|
$
|
567
|
|
Restricted cash
|
1
|
|
|
1
|
|
||
Accounts receivable, net
|
2,736
|
|
|
2,487
|
|
||
Inventories (Note 3)
|
1,326
|
|
|
1,277
|
|
||
Other current assets (Note 4)
|
435
|
|
|
445
|
|
||
Total current assets
|
4,819
|
|
|
4,777
|
|
||
Long-term assets:
|
|
|
|
||||
Property, net
|
3,218
|
|
|
3,179
|
|
||
Operating lease right-of-use assets (Note 22)
|
434
|
|
|
—
|
|
||
Investments in affiliates
|
102
|
|
|
99
|
|
||
Intangible assets, net (Note 2)
|
1,334
|
|
|
1,380
|
|
||
Goodwill (Note 2)
|
2,503
|
|
|
2,524
|
|
||
Other long-term assets (Note 4)
|
609
|
|
|
521
|
|
||
Total long-term assets
|
8,200
|
|
|
7,703
|
|
||
Total assets
|
$
|
13,019
|
|
|
$
|
12,480
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Short-term debt (Note 8)
|
$
|
542
|
|
|
$
|
306
|
|
Accounts payable
|
2,340
|
|
|
2,334
|
|
||
Accrued liabilities (Note 5)
|
1,132
|
|
|
1,054
|
|
||
Total current liabilities
|
4,014
|
|
|
3,694
|
|
||
Long-term liabilities:
|
|
|
|
||||
Long-term debt (Note 8)
|
3,995
|
|
|
4,038
|
|
||
Pension benefit obligations
|
440
|
|
|
445
|
|
||
Long-term operating lease liabilities (Note 22)
|
350
|
|
|
—
|
|
||
Other long-term liabilities (Note 5)
|
585
|
|
|
633
|
|
||
Total long-term liabilities
|
5,370
|
|
|
5,116
|
|
||
Total liabilities
|
9,384
|
|
|
8,810
|
|
||
Commitments and contingencies (Note 10)
|
|
|
|
|
|
||
Shareholders’ equity:
|
|
|
|
||||
Preferred shares, $0.01 par value per share, 50,000,000 shares authorized, none issued and outstanding
|
—
|
|
|
—
|
|
||
Ordinary shares, $0.01 par value per share, 1,200,000,000 shares authorized, 257,840,184 and 259,991,022 issued and outstanding as of March 31, 2019 and December 31, 2018, respectively
|
3
|
|
|
3
|
|
||
Additional paid-in-capital
|
1,606
|
|
|
1,639
|
|
||
Retained earnings
|
2,491
|
|
|
2,511
|
|
||
Accumulated other comprehensive loss (Note 13)
|
(682
|
)
|
|
(694
|
)
|
||
Total Aptiv shareholders’ equity
|
3,418
|
|
|
3,459
|
|
||
Noncontrolling interest
|
217
|
|
|
211
|
|
||
Total shareholders’ equity
|
3,635
|
|
|
3,670
|
|
||
Total liabilities and shareholders’ equity
|
$
|
13,019
|
|
|
$
|
12,480
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
245
|
|
|
$
|
316
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation
|
139
|
|
|
125
|
|
||
Amortization
|
34
|
|
|
30
|
|
||
Amortization of deferred debt issuance costs
|
2
|
|
|
2
|
|
||
Restructuring expense, net of cash paid
|
(5
|
)
|
|
(16
|
)
|
||
Deferred income taxes
|
4
|
|
|
(7
|
)
|
||
Pension and other postretirement benefit expenses
|
10
|
|
|
11
|
|
||
Income from equity method investments, net of dividends received
|
(3
|
)
|
|
(5
|
)
|
||
Loss on extinguishment of debt
|
6
|
|
|
—
|
|
||
Share-based compensation
|
15
|
|
|
13
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable, net
|
(249
|
)
|
|
(206
|
)
|
||
Inventories
|
(49
|
)
|
|
(119
|
)
|
||
Other assets
|
(45
|
)
|
|
(49
|
)
|
||
Accounts payable
|
53
|
|
|
140
|
|
||
Accrued and other long-term liabilities
|
(35
|
)
|
|
2
|
|
||
Other, net
|
(30
|
)
|
|
(40
|
)
|
||
Pension contributions
|
(8
|
)
|
|
(11
|
)
|
||
Net cash provided by operating activities from continuing operations
|
84
|
|
|
186
|
|
||
Net cash used in operating activities from discontinued operations
|
—
|
|
|
(31
|
)
|
||
Net cash provided by operating activities
|
84
|
|
|
155
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Capital expenditures
|
(235
|
)
|
|
(243
|
)
|
||
Proceeds from sale of property / investments
|
3
|
|
|
3
|
|
||
Cost of business acquisitions, net of cash acquired
|
2
|
|
|
—
|
|
||
Deposit for acquisition of KUM
|
—
|
|
|
(5
|
)
|
||
Cost of technology investments
|
(3
|
)
|
|
—
|
|
||
Settlement of derivatives
|
(2
|
)
|
|
—
|
|
||
Net cash used in investing activities
|
(235
|
)
|
|
(245
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Net proceeds under other short-term debt agreements
|
229
|
|
|
35
|
|
||
Repayment of senior notes
|
(654
|
)
|
|
—
|
|
||
Proceeds from issuance of senior notes, net of issuance costs
|
643
|
|
|
—
|
|
||
Repurchase of ordinary shares
|
(226
|
)
|
|
(149
|
)
|
||
Distribution of cash dividends
|
(57
|
)
|
|
(59
|
)
|
||
Taxes withheld and paid on employees’ restricted share awards
|
(34
|
)
|
|
(32
|
)
|
||
Net cash used in financing activities
|
(99
|
)
|
|
(205
|
)
|
||
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash
|
4
|
|
|
44
|
|
||
Decrease in cash, cash equivalents and restricted cash
|
(246
|
)
|
|
(251
|
)
|
||
Cash, cash equivalents and restricted cash at beginning of the period
|
568
|
|
|
1,597
|
|
||
Cash, cash equivalents and restricted cash at end of the period
|
$
|
322
|
|
|
$
|
1,346
|
|
|
Ordinary Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Number of Shares
|
|
Amount
|
|
Additional Paid in Capital
|
|
Retained Earnings
|
|
Accumulated Other Comprehensive Loss
|
|
Total Aptiv Shareholders’ Equity
|
|
Noncontrolling Interest
|
|
Total Shareholders’ Equity
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
(in millions)
|
|||||||||||||||||||||||||||||
Balance at January 1, 2019
|
260
|
|
|
$
|
3
|
|
|
$
|
1,639
|
|
|
$
|
2,511
|
|
|
$
|
(694
|
)
|
|
$
|
3,459
|
|
|
$
|
211
|
|
|
$
|
3,670
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
240
|
|
|
—
|
|
|
240
|
|
|
5
|
|
|
245
|
|
|||||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
21
|
|
|
21
|
|
|
1
|
|
|
22
|
|
|||||||
Dividends on ordinary shares
|
—
|
|
|
—
|
|
|
1
|
|
|
(58
|
)
|
|
—
|
|
|
(57
|
)
|
|
—
|
|
|
(57
|
)
|
|||||||
Taxes withheld on employees’ restricted share award vestings
|
—
|
|
|
—
|
|
|
(34
|
)
|
|
—
|
|
|
—
|
|
|
(34
|
)
|
|
—
|
|
|
(34
|
)
|
|||||||
Repurchase of ordinary shares
|
(3
|
)
|
|
—
|
|
|
(15
|
)
|
|
(211
|
)
|
|
—
|
|
|
(226
|
)
|
|
—
|
|
|
(226
|
)
|
|||||||
Share-based compensation
|
1
|
|
|
—
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|
15
|
|
|
—
|
|
|
15
|
|
|||||||
Adjustment for recently adopted accounting pronouncements (Note 2)
|
—
|
|
|
—
|
|
|
—
|
|
|
9
|
|
|
(9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Balance at March 31, 2019
|
258
|
|
|
$
|
3
|
|
|
$
|
1,606
|
|
|
$
|
2,491
|
|
|
$
|
(682
|
)
|
|
$
|
3,418
|
|
|
$
|
217
|
|
|
$
|
3,635
|
|
|
Ordinary Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Number of Shares
|
|
Amount
|
|
Additional Paid in Capital
|
|
Retained Earnings
|
|
Accumulated Other Comprehensive Loss
|
|
Total Aptiv Shareholders’ Equity
|
|
Noncontrolling Interest
|
|
Total Shareholders’ Equity
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
(in millions)
|
|||||||||||||||||||||||||||||
Balance at January 1, 2018
|
266
|
|
|
$
|
3
|
|
|
$
|
1,649
|
|
|
$
|
2,118
|
|
|
$
|
(471
|
)
|
|
$
|
3,299
|
|
|
$
|
218
|
|
|
$
|
3,517
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
307
|
|
|
—
|
|
|
307
|
|
|
9
|
|
|
316
|
|
|||||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
35
|
|
|
35
|
|
|
4
|
|
|
39
|
|
|||||||
Taxes withheld on employees’ restricted share award vestings
|
—
|
|
|
—
|
|
|
(32
|
)
|
|
—
|
|
|
—
|
|
|
(32
|
)
|
|
—
|
|
|
(32
|
)
|
|||||||
Repurchase of ordinary shares
|
(2
|
)
|
|
—
|
|
|
(8
|
)
|
|
(141
|
)
|
|
—
|
|
|
(149
|
)
|
|
—
|
|
|
(149
|
)
|
|||||||
Share-based compensation
|
1
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|||||||
Distribution of Delphi Technologies
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
3
|
|
|||||||
Adjustment for recently adopted accounting pronouncements
|
—
|
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
(9
|
)
|
|||||||
Balance at March 31, 2018
|
265
|
|
|
$
|
3
|
|
|
$
|
1,622
|
|
|
$
|
2,278
|
|
|
$
|
(436
|
)
|
|
$
|
3,467
|
|
|
$
|
231
|
|
|
$
|
3,698
|
|
|
Percentage of Total Net Sales
|
|
|
Accounts and Other Receivables
|
||||||||||
|
Three Months Ended March 31,
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||||||
|
2019
|
|
2018
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
(in millions)
|
||||||||
GM
|
10
|
%
|
|
11
|
%
|
|
|
$
|
252
|
|
|
$
|
169
|
|
VW
|
8
|
%
|
|
8
|
%
|
|
|
134
|
|
|
149
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Productive material
|
$
|
761
|
|
|
$
|
724
|
|
Work-in-process
|
107
|
|
|
101
|
|
||
Finished goods
|
458
|
|
|
452
|
|
||
Total
|
$
|
1,326
|
|
|
$
|
1,277
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Value added tax receivable
|
$
|
195
|
|
|
$
|
185
|
|
Prepaid insurance and other expenses
|
86
|
|
|
72
|
|
||
Reimbursable engineering costs
|
44
|
|
|
47
|
|
||
Notes receivable
|
35
|
|
|
43
|
|
||
Income and other taxes receivable
|
42
|
|
|
73
|
|
||
Deposits to vendors
|
7
|
|
|
4
|
|
||
Derivative financial instruments (Note 14)
|
5
|
|
|
6
|
|
||
Capitalized upfront fees (Note 21)
|
15
|
|
|
8
|
|
||
Other
|
6
|
|
|
7
|
|
||
Total
|
$
|
435
|
|
|
$
|
445
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Deferred income taxes, net
|
$
|
152
|
|
|
$
|
143
|
|
Unamortized Revolving Credit Facility debt issuance costs (Note 8)
|
5
|
|
|
6
|
|
||
Income and other taxes receivable
|
27
|
|
|
6
|
|
||
Reimbursable engineering costs
|
166
|
|
|
137
|
|
||
Value added tax receivable
|
39
|
|
|
38
|
|
||
Equity investments (Note 17)
|
94
|
|
|
72
|
|
||
Derivative financial instruments (Note 14)
|
4
|
|
|
2
|
|
||
Capitalized upfront fees (Note 21)
|
67
|
|
|
64
|
|
||
Other
|
55
|
|
|
53
|
|
||
Total
|
$
|
609
|
|
|
$
|
521
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Payroll-related obligations
|
$
|
241
|
|
|
$
|
235
|
|
Employee benefits, including current pension obligations
|
55
|
|
|
96
|
|
||
Income and other taxes payable
|
189
|
|
|
187
|
|
||
Warranty obligations (Note 6)
|
30
|
|
|
33
|
|
||
Restructuring (Note 7)
|
59
|
|
|
55
|
|
||
Customer deposits
|
61
|
|
|
36
|
|
||
Derivative financial instruments (Note 14)
|
8
|
|
|
19
|
|
||
Accrued interest
|
24
|
|
|
42
|
|
||
Deferred compensation related to nuTonomy acquisition
|
38
|
|
|
31
|
|
||
Operating lease liabilities (Note 22)
|
93
|
|
|
—
|
|
||
Other
|
334
|
|
|
320
|
|
||
Total
|
$
|
1,132
|
|
|
$
|
1,054
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Environmental (Note 10)
|
$
|
4
|
|
|
$
|
3
|
|
Extended disability benefits
|
5
|
|
|
5
|
|
||
Warranty obligations (Note 6)
|
17
|
|
|
17
|
|
||
Restructuring (Note 7)
|
39
|
|
|
49
|
|
||
Payroll-related obligations
|
10
|
|
|
10
|
|
||
Accrued income taxes
|
170
|
|
|
201
|
|
||
Deferred income taxes, net
|
242
|
|
|
233
|
|
||
Derivative financial instruments (Note 14)
|
3
|
|
|
9
|
|
||
Deferred compensation related to nuTonomy acquisition
|
22
|
|
|
18
|
|
||
Other
|
73
|
|
|
88
|
|
||
Total
|
$
|
585
|
|
|
$
|
633
|
|
|
Warranty Obligations
|
||
|
|
||
|
(in millions)
|
||
Accrual balance at beginning of period
|
$
|
50
|
|
Provision for estimated warranties incurred during the period
|
8
|
|
|
Changes in estimate for pre-existing warranties
|
—
|
|
|
Settlements made during the period (in cash or in kind)
|
(11
|
)
|
|
Foreign currency translation and other
|
—
|
|
|
Accrual balance at end of period
|
$
|
47
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Signal and Power Solutions
|
$
|
19
|
|
|
$
|
18
|
|
Advanced Safety and User Experience
|
7
|
|
|
2
|
|
||
Total
|
$
|
26
|
|
|
$
|
20
|
|
|
Employee Termination Benefits Liability
|
|
Other Exit Costs Liability
|
|
Total
|
||||||
|
|
|
|
|
|
||||||
|
(in millions)
|
||||||||||
Accrual balance at January 1, 2019
|
$
|
104
|
|
|
$
|
—
|
|
|
$
|
104
|
|
Provision for estimated expenses incurred during the period
|
26
|
|
|
—
|
|
|
26
|
|
|||
Payments made during the period
|
(31
|
)
|
|
—
|
|
|
(31
|
)
|
|||
Foreign currency and other
|
(1
|
)
|
|
—
|
|
|
(1
|
)
|
|||
Accrual balance at March 31, 2019
|
$
|
98
|
|
|
$
|
—
|
|
|
$
|
98
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Accounts receivable factoring
|
$
|
335
|
|
|
$
|
279
|
|
Revolving Credit Facility
|
175
|
|
|
—
|
|
||
3.15%, senior notes, due 2020 (net of $0 and $1 unamortized issuance costs and $0 and $1 discount, respectively)
|
—
|
|
|
648
|
|
||
4.15%, senior notes, due 2024 (net of $3 and $3 unamortized issuance costs and $1 and $1 discount, respectively)
|
696
|
|
|
696
|
|
||
1.50%, Euro-denominated senior notes, due 2025 (net of $3 and $3 unamortized issuance costs and $2 and $3 discount, respectively)
|
782
|
|
|
795
|
|
||
4.25%, senior notes, due 2026 (net of $3 and $3 unamortized issuance costs, respectively)
|
647
|
|
|
647
|
|
||
1.60%, Euro-denominated senior notes, due 2028 (net of $3 and $3 unamortized issuance costs and $1 and $1 discount, respectively)
|
558
|
|
|
568
|
|
||
4.35%, senior notes, due 2029 (net of $2 and $0 unamortized issuance costs, respectively)
|
298
|
|
|
—
|
|
||
4.40%, senior notes, due 2046 (net of $3 and $3 unamortized issuance costs and $2 and $2 discount, respectively)
|
295
|
|
|
295
|
|
||
5.40%, senior notes, due 2049 (net of $3 and $0 unamortized issuance costs and $2 and $0 discount, respectively)
|
345
|
|
|
—
|
|
||
Tranche A Term Loan, due 2021 (net of $1 and $1 unamortized issuance costs, respectively)
|
379
|
|
|
384
|
|
||
Finance leases and other
|
27
|
|
|
32
|
|
||
Total debt
|
4,537
|
|
|
4,344
|
|
||
Less: current portion
|
(542
|
)
|
|
(306
|
)
|
||
Long-term debt
|
$
|
3,995
|
|
|
$
|
4,038
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||||||
|
LIBOR plus
|
|
ABR plus
|
|
LIBOR plus
|
|
ABR plus
|
||||
Revolving Credit Facility
|
1.10
|
%
|
|
0.10
|
%
|
|
1.10
|
%
|
|
0.10
|
%
|
Tranche A Term Loan
|
1.25
|
%
|
|
0.25
|
%
|
|
1.25
|
%
|
|
0.25
|
%
|
|
|
|
Borrowings as of
|
|
|
|||
|
|
|
March 31, 2019
|
|
Rates effective as of
|
|||
|
Applicable Rate
|
|
(in millions)
|
|
March 31, 2019
|
|||
Revolving Credit Facility
|
ABR plus 0.10%
|
|
$
|
25
|
|
|
5.60
|
%
|
Revolving Credit Facility
|
LIBOR plus 1.10%
|
|
$
|
150
|
|
|
3.60
|
%
|
Tranche A Term Loan
|
LIBOR plus 1.25%
|
|
$
|
380
|
|
|
3.75
|
%
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
||||||||||||
|
|
|
|
|
|
|
|
||||||||
|
Three Months Ended March 31,
|
||||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
Service cost
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Interest cost
|
7
|
|
|
7
|
|
|
—
|
|
|
—
|
|
||||
Expected return on plan assets
|
(5
|
)
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
||||
Curtailment loss
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
||||
Amortization of actuarial losses
|
3
|
|
|
4
|
|
|
—
|
|
|
—
|
|
||||
Net periodic benefit cost
|
$
|
10
|
|
|
$
|
11
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
|
(dollars in millions)
|
||||||
Income tax expense
|
$
|
33
|
|
|
$
|
59
|
|
Effective tax rate
|
12
|
%
|
|
16
|
%
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
|
(in millions, except per share data)
|
||||||
Numerator:
|
|
|
|
||||
Net income attributable to Aptiv
|
$
|
240
|
|
|
$
|
307
|
|
Denominator:
|
|
|
|
||||
Weighted average ordinary shares outstanding, basic
|
259.08
|
|
|
265.69
|
|
||
Dilutive shares related to restricted stock units (“RSUs”)
|
0.47
|
|
|
0.75
|
|
||
Weighted average ordinary shares outstanding, including dilutive shares
|
259.55
|
|
|
266.44
|
|
||
|
|
|
|
||||
Net income per share attributable to Aptiv:
|
|
|
|
||||
Basic
|
$
|
0.93
|
|
|
$
|
1.16
|
|
Diluted
|
$
|
0.92
|
|
|
$
|
1.15
|
|
Anti-dilutive securities share impact
|
—
|
|
|
—
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Total number of shares repurchased
|
2,840,079
|
|
|
1,676,144
|
|
||
Average price paid per share
|
$
|
79.57
|
|
|
$
|
89.17
|
|
Total (in millions)
|
$
|
226
|
|
|
$
|
149
|
|
|
Dividend
|
|
Amount
|
||||
|
Per Share
|
|
(in millions)
|
||||
2019:
|
|
|
|
||||
First quarter
|
$
|
0.22
|
|
|
$
|
57
|
|
Total
|
$
|
0.22
|
|
|
$
|
57
|
|
2018:
|
|
|
|
||||
Fourth quarter
|
$
|
0.22
|
|
|
$
|
58
|
|
Third quarter
|
0.22
|
|
|
58
|
|
||
Second quarter
|
0.22
|
|
|
58
|
|
||
First quarter
|
0.22
|
|
|
59
|
|
||
Total
|
$
|
0.88
|
|
|
$
|
233
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Foreign currency translation adjustments:
|
|
|
|
||||
Balance at beginning of period
|
$
|
(555
|
)
|
|
$
|
(369
|
)
|
Aggregate adjustment for the period (1)
|
—
|
|
|
57
|
|
||
Balance at end of period
|
(555
|
)
|
|
(312
|
)
|
||
|
|
|
|
||||
Gains (losses) on derivatives:
|
|
|
|
||||
Balance at beginning of period
|
(35
|
)
|
|
4
|
|
||
Other comprehensive income (loss) before reclassifications (net tax effect of $0 and $4)
|
16
|
|
|
(18
|
)
|
||
Reclassification to income (net tax effect of $0 and $1)
|
3
|
|
|
(5
|
)
|
||
Adoption of ASU 2018-02 (Note 2)
|
(8
|
)
|
|
—
|
|
||
Balance at end of period
|
(24
|
)
|
|
(19
|
)
|
||
|
|
|
|
||||
Pension and postretirement plans:
|
|
|
|
||||
Balance at beginning of period
|
(104
|
)
|
|
(106
|
)
|
||
Other comprehensive income (loss) before reclassifications (net tax effect of $0 and $1)
|
—
|
|
|
(3
|
)
|
||
Reclassification to income (net tax effect of $1 and $0)
|
2
|
|
|
4
|
|
||
Adoption of ASU 2018-02 (Note 2)
|
(1
|
)
|
|
—
|
|
||
Balance at end of period
|
(103
|
)
|
|
(105
|
)
|
||
|
|
|
|
||||
Accumulated other comprehensive loss, end of period
|
$
|
(682
|
)
|
|
$
|
(436
|
)
|
(1)
|
Includes gains of $23 million and losses of $37 million for the three months ended March 31, 2019 and 2018, respectively, related to non-derivative net investment hedges. Refer to Note 14. Derivatives and Hedging Activities for further description of these hedges.
|
(1)
|
These accumulated other comprehensive loss components are included in the computation of net periodic pension cost (see Note 9. Pension Benefits for additional details).
|
Commodity
|
Quantity Hedged
|
|
Unit of Measure
|
|
Notional Amount
(Approximate USD Equivalent) |
|||
|
|
|
|
|
|
|||
|
(in thousands)
|
|
(in millions)
|
|||||
Copper
|
76,959
|
|
|
pounds
|
|
$
|
225
|
|
Foreign Currency
|
Quantity Hedged
|
|
Unit of Measure
|
|
Notional Amount
(Approximate USD Equivalent)
|
|||
|
|
|
|
|
|
|||
|
(in millions)
|
|||||||
Mexican Peso
|
14,183
|
|
|
MXN
|
|
$
|
730
|
|
Chinese Yuan Renminbi
|
3,284
|
|
|
RMB
|
|
490
|
|
|
Polish Zloty
|
505
|
|
|
PLN
|
|
130
|
|
|
Euro
|
62
|
|
|
EUR
|
|
70
|
|
|
New Turkish Lira
|
50
|
|
|
TRY
|
|
10
|
|
|
Asset Derivatives
|
|
Liability Derivatives
|
|
Net Amounts of Assets and (Liabilities) Presented in the Balance Sheet
|
||||||||||
|
Balance Sheet Location
|
|
March 31,
2019 |
|
Balance Sheet Location
|
|
March 31,
2019 |
|
March 31,
2019 |
||||||
|
|
|
|
|
|
|
|
|
|
||||||
|
(in millions)
|
||||||||||||||
Derivatives designated as cash flow hedges:
|
|
|
|
|
|
|
|
|
|||||||
Commodity derivatives
|
Other current assets
|
|
$
|
—
|
|
|
Accrued liabilities
|
|
$
|
2
|
|
|
|
||
Foreign currency derivatives*
|
Other current assets
|
|
9
|
|
|
Other current assets
|
|
4
|
|
|
$
|
5
|
|
||
Foreign currency derivatives*
|
Accrued liabilities
|
|
2
|
|
|
Accrued liabilities
|
|
8
|
|
|
(6
|
)
|
|||
Commodity derivatives
|
Other long-term assets
|
|
2
|
|
|
Other long-term liabilities
|
|
—
|
|
|
|
||||
Foreign currency derivatives*
|
Other long-term assets
|
|
3
|
|
|
Other long-term assets
|
|
1
|
|
|
2
|
|
|||
Foreign currency derivatives*
|
Other long-term liabilities
|
|
1
|
|
|
Other long-term liabilities
|
|
4
|
|
|
(3
|
)
|
|||
Total derivatives designated as hedges
|
|
$
|
17
|
|
|
|
|
$
|
19
|
|
|
|
|
Asset Derivatives
|
|
Liability Derivatives
|
|
Net Amounts of Assets and (Liabilities) Presented in the Balance Sheet
|
||||||||||
|
Balance Sheet Location
|
|
December 31,
2018 |
|
Balance Sheet Location
|
|
December 31,
2018 |
|
December 31,
2018 |
||||||
|
|
|
|
|
|
|
|
|
|
||||||
|
(in millions)
|
||||||||||||||
Derivatives designated as cash flow hedges:
|
|
|
|
|
|
|
|
|
|||||||
Commodity derivatives
|
Other current assets
|
|
$
|
—
|
|
|
Accrued liabilities
|
|
$
|
15
|
|
|
|
||
Foreign currency derivatives*
|
Other current assets
|
|
9
|
|
|
Other current assets
|
|
3
|
|
|
$
|
6
|
|
||
Foreign currency derivatives*
|
Accrued liabilities
|
|
—
|
|
|
Accrued liabilities
|
|
4
|
|
|
(4
|
)
|
|||
Commodity derivatives
|
Other long-term assets
|
|
—
|
|
|
Other long-term liabilities
|
|
7
|
|
|
|
||||
Foreign currency derivatives*
|
Other long-term assets
|
|
2
|
|
|
Other long-term assets
|
|
—
|
|
|
2
|
|
|||
Foreign currency derivatives*
|
Other long-term liabilities
|
|
—
|
|
|
Other long-term liabilities
|
|
2
|
|
|
(2
|
)
|
|||
Total derivatives designated as hedges
|
|
$
|
11
|
|
|
|
|
$
|
31
|
|
|
|
*
|
Derivative instruments within this category are subject to master netting arrangements and are presented on a net basis in the consolidated balance sheets in accordance with accounting guidance related to the offsetting of amounts related to certain contracts.
|
Three Months Ended March 31, 2019
|
Gain (Loss) Recognized in OCI
|
|
Loss Reclassified from OCI into Income
|
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Derivatives designated as cash flow hedges:
|
|
|
|
||||
Commodity derivatives
|
$
|
20
|
|
|
$
|
(2
|
)
|
Foreign currency derivatives
|
(2
|
)
|
|
(1
|
)
|
||
Derivatives designated as net investment hedges:
|
|
|
|
||||
Foreign currency derivatives
|
(2
|
)
|
|
—
|
|
||
Total
|
$
|
16
|
|
|
$
|
(3
|
)
|
|
Gain Recognized in Income
|
||
|
|
||
|
(in millions)
|
||
Derivatives not designated:
|
|
||
Foreign currency derivatives
|
$
|
—
|
|
Total
|
$
|
—
|
|
Three Months Ended March 31, 2018
|
(Loss) Gain Recognized in OCI
|
|
Gain (Loss) Reclassified from OCI into Income
|
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Derivatives designated as cash flow hedges:
|
|
|
|
||||
Commodity derivatives
|
$
|
(17
|
)
|
|
$
|
9
|
|
Foreign currency derivatives
|
16
|
|
|
(5
|
)
|
||
Derivatives designated as net investment hedges:
|
|
|
|
||||
Foreign currency derivatives
|
(13
|
)
|
|
—
|
|
||
Total
|
$
|
(14
|
)
|
|
$
|
4
|
|
|
Gain Recognized in Income
|
||
|
|
||
|
(in millions)
|
||
Derivatives not designated:
|
|
||
Foreign currency derivatives
|
$
|
10
|
|
Total
|
$
|
10
|
|
|
Contingent Consideration Liability
|
||
|
|
||
|
(in millions)
|
||
Fair value at beginning of period
|
$
|
49
|
|
Additions
|
—
|
|
|
Payments
|
—
|
|
|
Interest accretion
|
1
|
|
|
Fair value at end of period
|
$
|
50
|
|
|
Total
|
|
Quoted Prices in Active Markets
Level 1 |
|
Significant Other Observable Inputs
Level 2 |
|
Significant Unobservable Inputs
Level 3 |
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
As of March 31, 2019:
|
|
||||||||||||||
Commodity derivatives
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
2
|
|
|
$
|
—
|
|
Foreign currency derivatives
|
7
|
|
|
—
|
|
|
7
|
|
|
—
|
|
||||
Total
|
$
|
9
|
|
|
$
|
—
|
|
|
$
|
9
|
|
|
$
|
—
|
|
As of December 31, 2018:
|
|
|
|
|
|
|
|
||||||||
Foreign currency derivatives
|
$
|
8
|
|
|
$
|
—
|
|
|
$
|
8
|
|
|
$
|
—
|
|
Total
|
$
|
8
|
|
|
$
|
—
|
|
|
$
|
8
|
|
|
$
|
—
|
|
|
Total
|
|
Quoted Prices in Active Markets
Level 1 |
|
Significant Other Observable Inputs
Level 2 |
|
Significant Unobservable Inputs
Level 3 |
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
As of March 31, 2019:
|
|
||||||||||||||
Commodity derivatives
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
2
|
|
|
$
|
—
|
|
Foreign currency derivatives
|
9
|
|
|
—
|
|
|
9
|
|
|
—
|
|
||||
Contingent consideration
|
50
|
|
|
—
|
|
|
—
|
|
|
50
|
|
||||
Total
|
$
|
61
|
|
|
$
|
—
|
|
|
$
|
11
|
|
|
$
|
50
|
|
As of December 31, 2018:
|
|
|
|
|
|
|
|
||||||||
Commodity derivatives
|
$
|
22
|
|
|
$
|
—
|
|
|
$
|
22
|
|
|
$
|
—
|
|
Foreign currency derivatives
|
6
|
|
|
—
|
|
|
6
|
|
|
—
|
|
||||
Contingent consideration
|
49
|
|
|
—
|
|
|
—
|
|
|
49
|
|
||||
Total
|
$
|
77
|
|
|
$
|
—
|
|
|
$
|
28
|
|
|
$
|
49
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
|
|
|
||||
|
(in millions)
|
||||||
Interest income
|
$
|
3
|
|
|
$
|
5
|
|
Loss on extinguishment of debt
|
(6
|
)
|
|
—
|
|
||
Components of net periodic benefit cost other than service cost (Note 9)
|
(5
|
)
|
|
(6
|
)
|
||
Benefits associated with acquisitions
|
—
|
|
|
11
|
|
||
Change in fair value of equity investments (Note 17)
|
19
|
|
|
—
|
|
||
Other, net
|
5
|
|
|
20
|
|
||
Other income, net
|
$
|
16
|
|
|
$
|
30
|
|
Purchase price, cash consideration, net of cash acquired
|
$
|
680
|
|
|
|
||
Property, plant and equipment
|
$
|
31
|
|
Intangible assets
|
226
|
|
|
Other assets, net
|
25
|
|
|
Identifiable net assets acquired
|
282
|
|
|
Goodwill resulting from purchase
|
398
|
|
|
Total purchase price allocation
|
$
|
680
|
|
Purchase price, cash consideration, net of cash acquired
|
$
|
515
|
|
Debt and pension liabilities assumed
|
11
|
|
|
Total consideration, net of cash acquired
|
$
|
526
|
|
|
|
||
Property, plant and equipment
|
$
|
121
|
|
Intangible assets
|
110
|
|
|
Other assets, net
|
31
|
|
|
Identifiable net assets acquired
|
262
|
|
|
Goodwill resulting from purchase
|
264
|
|
|
Total purchase price allocation
|
$
|
526
|
|
Investment Name
|
|
Segment
|
|
Investment Date
|
|
Investment
(in millions)
|
||
Affectiva, Inc.
|
|
Advanced Safety and User Experience
|
|
Q4 2018
|
|
$
|
15
|
|
Innoviz Technologies
|
|
Advanced Safety and User Experience
|
|
Q3 2017
|
|
15
|
|
|
LeddarTech, Inc.
|
|
Advanced Safety and User Experience
|
|
Q3 2017
|
|
10
|
|
|
Valens Semiconductor Ltd.
|
|
Signal and Power Solutions
|
|
Q2 2017
|
|
10
|
|
|
Otonomo Technologies Ltd.
|
|
Advanced Safety and User Experience
|
|
Q1 2017; Q1 2019
|
|
37
|
|
|
Quanergy Systems, Inc
|
|
Advanced Safety and User Experience
|
|
Q2 2015; Q1 2016
|
|
6
|
|
|
Other investments
|
|
Advanced Safety and User Experience
|
|
Q4 2018
|
|
1
|
|
|
|
|
|
|
|
|
$
|
94
|
|
Metric
|
2016 - 2019 Grants
|
|
|
2015 Grant
|
Average return on net assets (1)
|
50%
|
|
|
50%
|
Cumulative net income
|
25%
|
|
|
N/A
|
Cumulative earnings per share (2)
|
N/A
|
|
|
30%
|
Relative total shareholder return (3)
|
25%
|
|
|
20%
|
(1)
|
Average return on net assets is measured by tax-affected operating income divided by average net working capital plus average net property, plant and equipment for each calendar year during the respective performance period.
|
(2)
|
Cumulative earnings per share is measured by net income attributable to Aptiv divided by the weighted average number of diluted shares outstanding for the respective three-year performance period.
|
(3)
|
Relative total shareholder return is measured by comparing the average closing price per share of the Company’s ordinary shares for the specified trading days in the fourth quarter of the end of the performance period to the average closing price per share of the Company’s ordinary shares for the specified trading days in the fourth quarter of the year preceding the grant, including dividends, and assessed against a comparable measure of competitor and peer group companies.
|
Grant Date
|
|
RSUs Granted
|
|
Grant Date Fair Value
|
|
Time-Based Award Vesting Dates
|
|
Performance-Based Award Vesting Date
|
|||
|
|
|
|
|
|
|
|
|
|||
|
|
(in millions)
|
|
|
|
|
|||||
February 2015
|
|
0.90
|
|
|
$
|
76
|
|
|
Annually on anniversary of grant date, 2016 - 2018
|
|
December 31, 2017
|
February 2016
|
|
0.71
|
|
|
48
|
|
|
Annually on anniversary of grant date, 2017 - 2019
|
|
December 31, 2018
|
|
February 2017
|
|
0.80
|
|
|
63
|
|
|
Annually on anniversary of grant date, 2018 - 2020
|
|
December 31, 2019
|
|
February 2018
|
|
0.63
|
|
|
61
|
|
|
Annually on anniversary of grant date, 2019 - 2021
|
|
December 31, 2020
|
|
February 2019
|
|
0.71
|
|
|
62
|
|
|
Annually on anniversary of grant date, 2020 - 2022
|
|
December 31, 2021
|
|
RSUs
|
|
Weighted Average Grant
Date Fair Value
|
|||
|
(in thousands)
|
|
|
|||
Nonvested, January 1, 2019
|
1,879
|
|
|
$
|
81.24
|
|
Granted
|
855
|
|
|
86.75
|
|
|
Vested
|
(530
|
)
|
|
70.05
|
|
|
Forfeited
|
(28
|
)
|
|
83.83
|
|
|
Nonvested, March 31, 2019
|
2,176
|
|
|
86.10
|
|
|
Parent
|
|
Subsidiary Guarantors
|
|
Subsidiary Issuer/Guarantor
|
|
Non-Guarantor Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Net sales
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,575
|
|
|
$
|
—
|
|
|
$
|
3,575
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cost of sales
|
—
|
|
|
—
|
|
|
—
|
|
|
2,962
|
|
|
—
|
|
|
2,962
|
|
||||||
Selling, general and administrative
|
(39
|
)
|
|
—
|
|
|
—
|
|
|
295
|
|
|
—
|
|
|
256
|
|
||||||
Amortization
|
—
|
|
|
—
|
|
|
—
|
|
|
34
|
|
|
—
|
|
|
34
|
|
||||||
Restructuring
|
—
|
|
|
—
|
|
|
—
|
|
|
26
|
|
|
—
|
|
|
26
|
|
||||||
Total operating expenses
|
(39
|
)
|
|
—
|
|
|
—
|
|
|
3,317
|
|
|
—
|
|
|
3,278
|
|
||||||
Operating income
|
39
|
|
|
—
|
|
|
—
|
|
|
258
|
|
|
—
|
|
|
297
|
|
||||||
Interest (expense) income
|
(30
|
)
|
|
(48
|
)
|
|
(60
|
)
|
|
(17
|
)
|
|
117
|
|
|
(38
|
)
|
||||||
Other (expense) income, net
|
(6
|
)
|
|
—
|
|
|
36
|
|
|
103
|
|
|
(117
|
)
|
|
16
|
|
||||||
Income (loss) before income taxes and equity income
|
3
|
|
|
(48
|
)
|
|
(24
|
)
|
|
344
|
|
|
—
|
|
|
275
|
|
||||||
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
5
|
|
|
(38
|
)
|
|
—
|
|
|
(33
|
)
|
||||||
Income (loss) before equity income
|
3
|
|
|
(48
|
)
|
|
(19
|
)
|
|
306
|
|
|
—
|
|
|
242
|
|
||||||
Equity in net income of affiliates
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
3
|
|
||||||
Equity in net income (loss) of subsidiaries
|
237
|
|
|
218
|
|
|
25
|
|
|
—
|
|
|
(480
|
)
|
|
—
|
|
||||||
Net income (loss)
|
240
|
|
|
170
|
|
|
6
|
|
|
309
|
|
|
(480
|
)
|
|
245
|
|
||||||
Net income attributable to noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
5
|
|
||||||
Net income (loss) attributable to Aptiv
|
$
|
240
|
|
|
$
|
170
|
|
|
$
|
6
|
|
|
$
|
304
|
|
|
$
|
(480
|
)
|
|
$
|
240
|
|
|
Parent
|
|
Subsidiary Guarantors
|
|
Subsidiary Issuer/Guarantor
|
|
Non-Guarantor Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Net sales
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,630
|
|
|
$
|
—
|
|
|
$
|
3,630
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cost of sales
|
—
|
|
|
—
|
|
|
—
|
|
|
2,947
|
|
|
—
|
|
|
2,947
|
|
||||||
Selling, general and administrative
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
263
|
|
|
—
|
|
|
259
|
|
||||||
Amortization
|
—
|
|
|
—
|
|
|
—
|
|
|
30
|
|
|
—
|
|
|
30
|
|
||||||
Restructuring
|
—
|
|
|
—
|
|
|
—
|
|
|
20
|
|
|
—
|
|
|
20
|
|
||||||
Total operating expenses
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
3,260
|
|
|
—
|
|
|
3,256
|
|
||||||
Operating income
|
4
|
|
|
—
|
|
|
—
|
|
|
370
|
|
|
—
|
|
|
374
|
|
||||||
Interest (expense) income
|
(61
|
)
|
|
(7
|
)
|
|
(43
|
)
|
|
(1
|
)
|
|
78
|
|
|
(34
|
)
|
||||||
Other income (expense), net
|
—
|
|
|
—
|
|
|
—
|
|
|
108
|
|
|
(78
|
)
|
|
30
|
|
||||||
(Loss) income before income taxes and equity income
|
(57
|
)
|
|
(7
|
)
|
|
(43
|
)
|
|
477
|
|
|
—
|
|
|
370
|
|
||||||
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
10
|
|
|
(69
|
)
|
|
—
|
|
|
(59
|
)
|
||||||
(Loss) income before equity income
|
(57
|
)
|
|
(7
|
)
|
|
(33
|
)
|
|
408
|
|
|
—
|
|
|
311
|
|
||||||
Equity in net income of affiliates
|
—
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
5
|
|
||||||
Equity in net income (loss) of subsidiaries
|
364
|
|
|
263
|
|
|
(29
|
)
|
|
—
|
|
|
(598
|
)
|
|
—
|
|
||||||
Net income (loss)
|
307
|
|
|
256
|
|
|
(62
|
)
|
|
413
|
|
|
(598
|
)
|
|
316
|
|
||||||
Net income attributable to noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
9
|
|
|
—
|
|
|
9
|
|
||||||
Net income (loss) attributable to Aptiv
|
$
|
307
|
|
|
$
|
256
|
|
|
$
|
(62
|
)
|
|
$
|
404
|
|
|
$
|
(598
|
)
|
|
$
|
307
|
|
|
Parent
|
|
Subsidiary Guarantors
|
|
Subsidiary Issuer/Guarantor
|
|
Non-Guarantor Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Net income (loss)
|
$
|
240
|
|
|
$
|
170
|
|
|
$
|
6
|
|
|
$
|
309
|
|
|
$
|
(480
|
)
|
|
$
|
245
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Currency translation adjustments
|
23
|
|
|
—
|
|
|
—
|
|
|
(22
|
)
|
|
—
|
|
|
1
|
|
||||||
Net change in unrecognized gain on derivative instruments, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
19
|
|
|
—
|
|
|
19
|
|
||||||
Employee benefit plans adjustment, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
2
|
|
||||||
Other comprehensive income (loss)
|
23
|
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
22
|
|
||||||
Equity in other comprehensive (loss) income of subsidiaries
|
(2
|
)
|
|
19
|
|
|
(10
|
)
|
|
—
|
|
|
(7
|
)
|
|
—
|
|
||||||
Comprehensive income (loss)
|
261
|
|
|
189
|
|
|
(4
|
)
|
|
308
|
|
|
(487
|
)
|
|
267
|
|
||||||
Comprehensive income attributable to noncontrolling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
6
|
|
|
—
|
|
|
6
|
|
||||||
Comprehensive income (loss) attributable to Aptiv
|
$
|
261
|
|
|
$
|
189
|
|
|
$
|
(4
|
)
|
|
$
|
302
|
|
|
$
|
(487
|
)
|
|
$
|
261
|
|
|
Parent
|
|
Subsidiary Guarantors
|
|
Subsidiary Issuer/Guarantor
|
|
Non-Guarantor Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Net income (loss)
|
$
|
307
|
|
|
$
|
256
|
|
|
$
|
(62
|
)
|
|
$
|
413
|
|
|
$
|
(598
|
)
|
|
$
|
316
|
|
Other comprehensive (loss) income:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Currency translation adjustments
|
(37
|
)
|
|
—
|
|
|
—
|
|
|
98
|
|
|
—
|
|
|
61
|
|
||||||
Net change in unrecognized loss on derivative instruments, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(23
|
)
|
|
—
|
|
|
(23
|
)
|
||||||
Employee benefit plans adjustment, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
1
|
|
||||||
Other comprehensive (loss) income
|
(37
|
)
|
|
—
|
|
|
—
|
|
|
76
|
|
|
—
|
|
|
39
|
|
||||||
Equity in other comprehensive income (loss) of subsidiaries
|
72
|
|
|
17
|
|
|
21
|
|
|
—
|
|
|
(110
|
)
|
|
—
|
|
||||||
Comprehensive income (loss)
|
342
|
|
|
273
|
|
|
(41
|
)
|
|
489
|
|
|
(708
|
)
|
|
355
|
|
||||||
Comprehensive income attributable to noncontrolling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
||||||
Comprehensive income (loss) attributable to Aptiv
|
$
|
342
|
|
|
$
|
273
|
|
|
$
|
(41
|
)
|
|
$
|
476
|
|
|
$
|
(708
|
)
|
|
$
|
342
|
|
|
Parent
|
|
Subsidiary Guarantors
|
|
Subsidiary Issuer/Guarantor
|
|
Non-Guarantor Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
321
|
|
|
$
|
—
|
|
|
$
|
321
|
|
Restricted cash
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
1
|
|
||||||
Accounts receivable, net
|
—
|
|
|
—
|
|
|
—
|
|
|
2,736
|
|
|
—
|
|
|
2,736
|
|
||||||
Intercompany receivables, current
|
51
|
|
|
16
|
|
|
3,256
|
|
|
4,820
|
|
|
(8,143
|
)
|
|
—
|
|
||||||
Inventories
|
—
|
|
|
—
|
|
|
—
|
|
|
1,326
|
|
|
—
|
|
|
1,326
|
|
||||||
Other current assets
|
—
|
|
|
—
|
|
|
—
|
|
|
435
|
|
|
—
|
|
|
435
|
|
||||||
Total current assets
|
51
|
|
|
16
|
|
|
3,256
|
|
|
9,639
|
|
|
(8,143
|
)
|
|
4,819
|
|
||||||
Long-term assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Intercompany receivables, long-term
|
—
|
|
|
—
|
|
|
768
|
|
|
1,458
|
|
|
(2,226
|
)
|
|
—
|
|
||||||
Property, net
|
—
|
|
|
—
|
|
|
—
|
|
|
3,218
|
|
|
—
|
|
|
3,218
|
|
||||||
Operating lease right-of-use assets
|
—
|
|
|
—
|
|
|
—
|
|
|
434
|
|
|
—
|
|
|
434
|
|
||||||
Investments in affiliates
|
—
|
|
|
—
|
|
|
—
|
|
|
102
|
|
|
—
|
|
|
102
|
|
||||||
Investments in subsidiaries
|
7,632
|
|
|
8,143
|
|
|
1,779
|
|
|
—
|
|
|
(17,554
|
)
|
|
—
|
|
||||||
Intangible assets, net
|
—
|
|
|
—
|
|
|
—
|
|
|
3,837
|
|
|
—
|
|
|
3,837
|
|
||||||
Other long-term assets
|
—
|
|
|
—
|
|
|
5
|
|
|
604
|
|
|
—
|
|
|
609
|
|
||||||
Total long-term assets
|
7,632
|
|
|
8,143
|
|
|
2,552
|
|
|
9,653
|
|
|
(19,780
|
)
|
|
8,200
|
|
||||||
Total assets
|
$
|
7,683
|
|
|
$
|
8,159
|
|
|
$
|
5,808
|
|
|
$
|
19,292
|
|
|
$
|
(27,923
|
)
|
|
$
|
13,019
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Short-term debt
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
205
|
|
|
$
|
337
|
|
|
$
|
—
|
|
|
$
|
542
|
|
Accounts payable
|
—
|
|
|
—
|
|
|
—
|
|
|
2,340
|
|
|
—
|
|
|
2,340
|
|
||||||
Intercompany payables, current
|
1,103
|
|
|
4,527
|
|
|
2,513
|
|
|
—
|
|
|
(8,143
|
)
|
|
—
|
|
||||||
Accrued liabilities
|
20
|
|
|
—
|
|
|
4
|
|
|
1,108
|
|
|
—
|
|
|
1,132
|
|
||||||
Total current liabilities
|
1,123
|
|
|
4,527
|
|
|
2,722
|
|
|
3,785
|
|
|
(8,143
|
)
|
|
4,014
|
|
||||||
Long-term liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Long-term debt
|
2,925
|
|
|
—
|
|
|
1,045
|
|
|
25
|
|
|
—
|
|
|
3,995
|
|
||||||
Intercompany payables, long-term
|
—
|
|
|
—
|
|
|
1,315
|
|
|
911
|
|
|
(2,226
|
)
|
|
—
|
|
||||||
Pension benefit obligations
|
—
|
|
|
—
|
|
|
—
|
|
|
440
|
|
|
—
|
|
|
440
|
|
||||||
Long-term operating lease liabilities
|
—
|
|
|
—
|
|
|
—
|
|
|
350
|
|
|
—
|
|
|
350
|
|
||||||
Other long-term liabilities
|
—
|
|
|
—
|
|
|
—
|
|
|
585
|
|
|
—
|
|
|
585
|
|
||||||
Total long-term liabilities
|
2,925
|
|
|
—
|
|
|
2,360
|
|
|
2,311
|
|
|
(2,226
|
)
|
|
5,370
|
|
||||||
Total liabilities
|
4,048
|
|
|
4,527
|
|
|
5,082
|
|
|
6,096
|
|
|
(10,369
|
)
|
|
9,384
|
|
||||||
Total Aptiv shareholders’ equity
|
3,635
|
|
|
3,632
|
|
|
726
|
|
|
12,979
|
|
|
(17,554
|
)
|
|
3,418
|
|
||||||
Noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
217
|
|
|
—
|
|
|
217
|
|
||||||
Total shareholders’ equity
|
3,635
|
|
|
3,632
|
|
|
726
|
|
|
13,196
|
|
|
(17,554
|
)
|
|
3,635
|
|
||||||
Total liabilities and shareholders’ equity
|
$
|
7,683
|
|
|
$
|
8,159
|
|
|
$
|
5,808
|
|
|
$
|
19,292
|
|
|
$
|
(27,923
|
)
|
|
$
|
13,019
|
|
|
Parent
|
|
Subsidiary Guarantors
|
|
Subsidiary Issuer/Guarantor
|
|
Non-Guarantor Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
566
|
|
|
$
|
—
|
|
|
$
|
567
|
|
Restricted cash
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
1
|
|
||||||
Accounts receivable, net
|
—
|
|
|
—
|
|
|
—
|
|
|
2,487
|
|
|
—
|
|
|
2,487
|
|
||||||
Intercompany receivables, current
|
54
|
|
|
16
|
|
|
3,114
|
|
|
4,201
|
|
|
(7,385
|
)
|
|
—
|
|
||||||
Inventories
|
—
|
|
|
—
|
|
|
—
|
|
|
1,277
|
|
|
—
|
|
|
1,277
|
|
||||||
Other current assets
|
—
|
|
|
—
|
|
|
—
|
|
|
445
|
|
|
—
|
|
|
445
|
|
||||||
Total current assets
|
55
|
|
|
16
|
|
|
3,114
|
|
|
8,977
|
|
|
(7,385
|
)
|
|
4,777
|
|
||||||
Long-term assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Intercompany receivables, long-term
|
—
|
|
|
—
|
|
|
768
|
|
|
1,424
|
|
|
(2,192
|
)
|
|
—
|
|
||||||
Property, net
|
—
|
|
|
—
|
|
|
—
|
|
|
3,179
|
|
|
—
|
|
|
3,179
|
|
||||||
Investments in affiliates
|
—
|
|
|
—
|
|
|
—
|
|
|
99
|
|
|
—
|
|
|
99
|
|
||||||
Investments in subsidiaries
|
7,392
|
|
|
7,860
|
|
|
1,568
|
|
|
—
|
|
|
(16,820
|
)
|
|
—
|
|
||||||
Intangible assets, net
|
—
|
|
|
—
|
|
|
—
|
|
|
3,904
|
|
|
—
|
|
|
3,904
|
|
||||||
Other long-term assets
|
—
|
|
|
—
|
|
|
6
|
|
|
515
|
|
|
—
|
|
|
521
|
|
||||||
Total long-term assets
|
7,392
|
|
|
7,860
|
|
|
2,342
|
|
|
9,121
|
|
|
(19,012
|
)
|
|
7,703
|
|
||||||
Total assets
|
$
|
7,447
|
|
|
$
|
7,876
|
|
|
$
|
5,456
|
|
|
$
|
18,098
|
|
|
$
|
(26,397
|
)
|
|
$
|
12,480
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Short-term debt
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
25
|
|
|
$
|
281
|
|
|
$
|
—
|
|
|
$
|
306
|
|
Accounts payable
|
2
|
|
|
—
|
|
|
—
|
|
|
2,332
|
|
|
—
|
|
|
2,334
|
|
||||||
Intercompany payables, current
|
791
|
|
|
4,479
|
|
|
2,115
|
|
|
—
|
|
|
(7,385
|
)
|
|
—
|
|
||||||
Accrued liabilities
|
31
|
|
|
—
|
|
|
11
|
|
|
1,012
|
|
|
—
|
|
|
1,054
|
|
||||||
Total current liabilities
|
824
|
|
|
4,479
|
|
|
2,151
|
|
|
3,625
|
|
|
(7,385
|
)
|
|
3,694
|
|
||||||
Long-term liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Long-term debt
|
2,953
|
|
|
—
|
|
|
1,055
|
|
|
30
|
|
|
—
|
|
|
4,038
|
|
||||||
Intercompany payables, long-term
|
—
|
|
|
—
|
|
|
1,296
|
|
|
896
|
|
|
(2,192
|
)
|
|
—
|
|
||||||
Pension benefit obligations
|
—
|
|
|
—
|
|
|
—
|
|
|
445
|
|
|
—
|
|
|
445
|
|
||||||
Other long-term liabilities
|
—
|
|
|
—
|
|
|
—
|
|
|
633
|
|
|
—
|
|
|
633
|
|
||||||
Total long-term liabilities
|
2,953
|
|
|
—
|
|
|
2,351
|
|
|
2,004
|
|
|
(2,192
|
)
|
|
5,116
|
|
||||||
Total liabilities
|
3,777
|
|
|
4,479
|
|
|
4,502
|
|
|
5,629
|
|
|
(9,577
|
)
|
|
8,810
|
|
||||||
Total Aptiv shareholders’ equity
|
3,670
|
|
|
3,397
|
|
|
954
|
|
|
12,258
|
|
|
(16,820
|
)
|
|
3,459
|
|
||||||
Noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
211
|
|
|
—
|
|
|
211
|
|
||||||
Total shareholders’ equity
|
3,670
|
|
|
3,397
|
|
|
954
|
|
|
12,469
|
|
|
(16,820
|
)
|
|
3,670
|
|
||||||
Total liabilities and shareholders’ equity
|
$
|
7,447
|
|
|
$
|
7,876
|
|
|
$
|
5,456
|
|
|
$
|
18,098
|
|
|
$
|
(26,397
|
)
|
|
$
|
12,480
|
|
|
Parent
|
|
Subsidiary Guarantors
|
|
Subsidiary Issuer/Guarantor
|
|
Non-Guarantor Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Net cash (used in) provided by operating activities from continuing operations
|
$
|
(10
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
94
|
|
|
$
|
—
|
|
|
$
|
84
|
|
Net cash used in operating activities from discontinued operations
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Net cash (used in) provided by operating activities
|
(10
|
)
|
|
—
|
|
|
—
|
|
|
94
|
|
|
—
|
|
|
84
|
|
||||||
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Capital expenditures
|
—
|
|
|
—
|
|
|
—
|
|
|
(235
|
)
|
|
—
|
|
|
(235
|
)
|
||||||
Proceeds from sale of property / investments
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
3
|
|
||||||
Cost of business acquisitions, net of cash acquired
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
2
|
|
||||||
Cost of technology investments
|
—
|
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
||||||
Settlement of derivatives
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
(2
|
)
|
||||||
Loans to affiliates
|
—
|
|
|
—
|
|
|
—
|
|
|
(303
|
)
|
|
303
|
|
|
—
|
|
||||||
Repayments of loans from affiliates
|
—
|
|
|
—
|
|
|
—
|
|
|
175
|
|
|
(175
|
)
|
|
—
|
|
||||||
Net cash (used in) provided by investing activities
|
—
|
|
|
—
|
|
|
—
|
|
|
(363
|
)
|
|
128
|
|
|
(235
|
)
|
||||||
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net proceeds under other short-term debt agreements
|
—
|
|
|
—
|
|
|
175
|
|
|
54
|
|
|
—
|
|
|
229
|
|
||||||
Repayment of senior notes
|
(654
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(654
|
)
|
||||||
Proceeds from issuance of senior notes, net of issuance costs
|
643
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
643
|
|
||||||
Proceeds from borrowings from affiliates
|
303
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(303
|
)
|
|
—
|
|
||||||
Payments on borrowings from affiliates
|
—
|
|
|
—
|
|
|
(175
|
)
|
|
—
|
|
|
175
|
|
|
—
|
|
||||||
Repurchase of ordinary shares
|
(226
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(226
|
)
|
||||||
Distribution of cash dividends
|
(57
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(57
|
)
|
||||||
Taxes withheld and paid on employees' restricted share awards
|
—
|
|
|
—
|
|
|
—
|
|
|
(34
|
)
|
|
—
|
|
|
(34
|
)
|
||||||
Net cash provided by (used in) financing activities
|
9
|
|
|
—
|
|
|
—
|
|
|
20
|
|
|
(128
|
)
|
|
(99
|
)
|
||||||
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash
|
—
|
|
|
—
|
|
|
—
|
|
|
4
|
|
|
—
|
|
|
4
|
|
||||||
Decrease in cash, cash equivalents and restricted cash
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
(245
|
)
|
|
—
|
|
|
(246
|
)
|
||||||
Cash, cash equivalents and restricted cash at beginning of period
|
1
|
|
|
—
|
|
|
—
|
|
|
567
|
|
|
—
|
|
|
568
|
|
||||||
Cash, cash equivalents and restricted cash at end of period
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
322
|
|
|
$
|
—
|
|
|
$
|
322
|
|
|
Parent
|
|
Subsidiary Guarantors
|
|
Subsidiary Issuer/Guarantor
|
|
Non-Guarantor Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Net cash (used in) provided by operating activities from continuing operations
|
$
|
(36
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
222
|
|
|
$
|
—
|
|
|
$
|
186
|
|
Net cash used in operating activities from discontinued operations
|
—
|
|
|
—
|
|
|
—
|
|
|
(31
|
)
|
|
—
|
|
|
(31
|
)
|
||||||
Net cash (used in) provided by operating activities
|
(36
|
)
|
|
—
|
|
|
—
|
|
|
191
|
|
|
—
|
|
|
155
|
|
||||||
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Capital expenditures
|
—
|
|
|
—
|
|
|
—
|
|
|
(243
|
)
|
|
—
|
|
|
(243
|
)
|
||||||
Proceeds from sale of property / investments
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
3
|
|
||||||
Deposit for acquisition of KUM
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
||||||
Loans to affiliates
|
—
|
|
|
—
|
|
|
—
|
|
|
(250
|
)
|
|
250
|
|
|
—
|
|
||||||
Net cash (used in) provided by investing activities
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
(490
|
)
|
|
250
|
|
|
(245
|
)
|
||||||
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net proceeds under other short-term debt agreements
|
—
|
|
|
—
|
|
|
—
|
|
|
35
|
|
|
—
|
|
|
35
|
|
||||||
Proceeds from borrowings from affiliates
|
250
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(250
|
)
|
|
—
|
|
||||||
Repurchase of ordinary shares
|
(149
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(149
|
)
|
||||||
Distribution of cash dividends
|
(59
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(59
|
)
|
||||||
Taxes withheld and paid on employees' restricted share awards
|
—
|
|
|
—
|
|
|
—
|
|
|
(32
|
)
|
|
—
|
|
|
(32
|
)
|
||||||
Net cash provided by (used in) financing activities
|
42
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
(250
|
)
|
|
(205
|
)
|
||||||
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash
|
—
|
|
|
—
|
|
|
—
|
|
|
44
|
|
|
—
|
|
|
44
|
|
||||||
Increase (decrease) in cash, cash equivalents and restricted cash
|
1
|
|
|
—
|
|
|
—
|
|
|
(252
|
)
|
|
—
|
|
|
(251
|
)
|
||||||
Cash, cash equivalents and restricted cash at beginning of period
|
1
|
|
|
—
|
|
|
—
|
|
|
1,596
|
|
|
—
|
|
|
1,597
|
|
||||||
Cash, cash equivalents and restricted cash at end of period
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,344
|
|
|
$
|
—
|
|
|
$
|
1,346
|
|
•
|
Signal and Power Solutions, which includes complete electrical architecture and component products.
|
•
|
Advanced Safety and User Experience, which includes component and systems integration expertise in infotainment and connectivity, body controls and security systems, active and passive safety electronics, autonomous driving software and technologies, as well as advanced development of software.
|
•
|
Eliminations and Other, which includes i) the elimination of inter-segment transactions, and ii) certain other expenses and income of a non-operating or strategic nature.
|
|
Signal and Power Solutions
|
|
Advanced Safety and User Experience
|
|
Eliminations and Other (1)
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
For the Three Months Ended March 31, 2019:
|
|
|
|
|
|
|
|
||||||||
Net sales
|
$
|
2,562
|
|
|
$
|
1,023
|
|
|
$
|
(10
|
)
|
|
$
|
3,575
|
|
Depreciation and amortization
|
$
|
131
|
|
|
$
|
42
|
|
|
$
|
—
|
|
|
$
|
173
|
|
Adjusted operating income
|
$
|
283
|
|
|
$
|
62
|
|
|
$
|
—
|
|
|
$
|
345
|
|
Operating income
|
$
|
257
|
|
|
$
|
40
|
|
|
$
|
—
|
|
|
$
|
297
|
|
Equity income, net of tax
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3
|
|
Net income attributable to noncontrolling interest
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5
|
|
|
Signal and Power Solutions
|
|
Advanced Safety and User Experience
|
|
Eliminations and Other (1)
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
For the Three Months Ended March 31, 2018:
|
|
|
|
|
|
|
|
||||||||
Net sales
|
$
|
2,617
|
|
|
$
|
1,032
|
|
|
$
|
(19
|
)
|
|
$
|
3,630
|
|
Depreciation and amortization
|
$
|
119
|
|
|
$
|
36
|
|
|
$
|
—
|
|
|
$
|
155
|
|
Adjusted operating income
|
$
|
351
|
|
|
$
|
76
|
|
|
$
|
—
|
|
|
$
|
427
|
|
Operating income
|
$
|
322
|
|
|
$
|
52
|
|
|
$
|
—
|
|
|
$
|
374
|
|
Equity income, net of tax
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5
|
|
Net income attributable to noncontrolling interest
|
$
|
9
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
9
|
|
(1)
|
Eliminations and Other includes the elimination of inter-segment transactions.
|
|
Signal and Power Solutions
|
|
Advanced Safety and User Experience
|
|
Eliminations and Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
For the Three Months Ended March 31, 2019:
|
|
|
|
|
|
|
|
||||||||
Adjusted operating income
|
$
|
283
|
|
|
$
|
62
|
|
|
$
|
—
|
|
|
$
|
345
|
|
Restructuring
|
(19
|
)
|
|
(7
|
)
|
|
—
|
|
|
(26
|
)
|
||||
Other acquisition and portfolio project costs
|
(7
|
)
|
|
(4
|
)
|
|
—
|
|
|
(11
|
)
|
||||
Deferred compensation related to nuTonomy acquisition
|
—
|
|
|
(11
|
)
|
|
—
|
|
|
(11
|
)
|
||||
Operating income
|
$
|
257
|
|
|
$
|
40
|
|
|
$
|
—
|
|
|
297
|
|
|
Interest expense
|
|
|
|
|
|
|
(38
|
)
|
|||||||
Other income, net
|
|
|
|
|
|
|
16
|
|
|||||||
Income before income taxes and equity income
|
|
|
|
|
|
|
275
|
|
|||||||
Income tax expense
|
|
|
|
|
|
|
(33
|
)
|
|||||||
Equity income, net of tax
|
|
|
|
|
|
|
3
|
|
|||||||
Net income
|
|
|
|
|
|
|
245
|
|
|||||||
Net income attributable to noncontrolling interest
|
|
|
|
|
|
|
5
|
|
|||||||
Net income attributable to Aptiv
|
|
|
|
|
|
|
$
|
240
|
|
|
Signal and Power Solutions
|
|
Advanced Safety and User Experience
|
|
Eliminations and Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
For the Three Months Ended March 31, 2018:
|
|
|
|
|
|
|
|
||||||||
Adjusted operating income
|
$
|
351
|
|
|
$
|
76
|
|
|
$
|
—
|
|
|
$
|
427
|
|
Restructuring
|
(18
|
)
|
|
(2
|
)
|
|
—
|
|
|
(20
|
)
|
||||
Other acquisition and portfolio project costs
|
(11
|
)
|
|
(8
|
)
|
|
—
|
|
|
(19
|
)
|
||||
Deferred compensation related to nuTonomy acquisition
|
—
|
|
|
(14
|
)
|
|
—
|
|
|
(14
|
)
|
||||
Operating income
|
$
|
322
|
|
|
$
|
52
|
|
|
$
|
—
|
|
|
374
|
|
|
Interest expense
|
|
|
|
|
|
|
(34
|
)
|
|||||||
Other income, net
|
|
|
|
|
|
|
30
|
|
|||||||
Income before income taxes and equity income
|
|
|
|
|
|
|
370
|
|
|||||||
Income tax expense
|
|
|
|
|
|
|
(59
|
)
|
|||||||
Equity income, net of tax
|
|
|
|
|
|
|
5
|
|
|||||||
Net income
|
|
|
|
|
|
|
316
|
|
|||||||
Net income attributable to noncontrolling interest
|
|
|
|
|
|
|
9
|
|
|||||||
Net income attributable to Aptiv
|
|
|
|
|
|
|
$
|
307
|
|
For the Three Months Ended March 31, 2019:
|
Signal and Power Solutions
|
|
Advanced Safety and User Experience
|
|
Eliminations and Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
Geographic Market
|
|
|
|
|
|
|
|
||||||||
North America
|
$
|
1,096
|
|
|
$
|
326
|
|
|
$
|
(1
|
)
|
|
$
|
1,421
|
|
Europe, Middle East and Africa
|
789
|
|
|
443
|
|
|
(3
|
)
|
|
1,229
|
|
||||
Asia Pacific
|
622
|
|
|
254
|
|
|
(6
|
)
|
|
870
|
|
||||
South America
|
55
|
|
|
—
|
|
|
—
|
|
|
55
|
|
||||
Total net sales
|
$
|
2,562
|
|
|
$
|
1,023
|
|
|
$
|
(10
|
)
|
|
$
|
3,575
|
|
For the Three Months Ended March 31, 2018:
|
Signal and Power Solutions
|
|
Advanced Safety and User Experience
|
|
Eliminations and Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
Geographic Market
|
|
|
|
|
|
|
|
||||||||
North America
|
$
|
1,020
|
|
|
$
|
335
|
|
|
$
|
(4
|
)
|
|
$
|
1,351
|
|
Europe, Middle East and Africa
|
837
|
|
|
437
|
|
|
(5
|
)
|
|
1,269
|
|
||||
Asia Pacific
|
687
|
|
|
259
|
|
|
(10
|
)
|
|
936
|
|
||||
South America
|
73
|
|
|
1
|
|
|
—
|
|
|
74
|
|
||||
Total net sales
|
$
|
2,617
|
|
|
$
|
1,032
|
|
|
$
|
(19
|
)
|
|
$
|
3,630
|
|
|
Three Months Ended March 31, 2019
|
||
|
|
||
|
(in millions)
|
||
Lease cost:
|
|
||
Finance lease cost:
|
|
||
Amortization of right-of-use assets
|
$
|
1
|
|
Interest on lease liabilities
|
—
|
|
|
Total finance lease cost
|
1
|
|
|
Operating lease cost
|
29
|
|
|
Short-term lease cost
|
1
|
|
|
Variable lease cost
|
1
|
|
|
Sublease income (1)
|
—
|
|
|
Total lease cost
|
$
|
32
|
|
(1)
|
Sublease income excludes rental income from owned properties of less than $5 million for the three months ended March 31, 2019, which is included in other income, net.
|
|
March 31, 2019
|
||
|
|
||
|
(dollars in millions)
|
||
Operating leases:
|
|
||
Operating lease right-of-use assets
|
$
|
434
|
|
Accrued liabilities (Note 5)
|
$
|
93
|
|
Long-term operating lease liabilities
|
350
|
|
|
Total operating lease liabilities
|
$
|
443
|
|
|
|
||
Finance leases:
|
|
||
Property and equipment
|
$
|
22
|
|
Less: accumulated depreciation
|
(5
|
)
|
|
Total property, net
|
$
|
17
|
|
Short-term debt (Note 8)
|
$
|
2
|
|
Long-term debt (Note 8)
|
16
|
|
|
Total finance lease liabilities
|
$
|
18
|
|
|
|
||
Weighted average remaining lease term:
|
|
||
Operating leases
|
7 years
|
|
|
Finance leases
|
7 years
|
|
|
|
|
||
Weighted average discount rate:
|
|
||
Operating leases
|
3.5
|
%
|
|
Finance leases
|
5.5
|
%
|
|
Operating Leases
|
|
Finance
Leases
|
||||
|
|
|
|
||||
|
(in millions)
|
||||||
As of March 31, 2019:
|
|
|
|
||||
2019 (remaining as of March 31, 2019)
|
$
|
80
|
|
|
$
|
3
|
|
2020
|
96
|
|
|
4
|
|
||
2021
|
83
|
|
|
4
|
|
||
2022
|
69
|
|
|
3
|
|
||
2023
|
51
|
|
|
3
|
|
||
Thereafter
|
120
|
|
|
7
|
|
||
Total lease payments
|
499
|
|
|
24
|
|
||
Less: imputed interest
|
(56
|
)
|
|
(6
|
)
|
||
Total
|
$
|
443
|
|
|
$
|
18
|
|
•
|
Executive Overview
|
•
|
Consolidated Results of Operations
|
•
|
Results of Operations by Segment
|
•
|
Liquidity and Capital Resources
|
•
|
Off-Balance Sheet Arrangements
|
•
|
Contingencies and Environmental Matters
|
•
|
Recently Issued Accounting Pronouncements
|
•
|
Critical Accounting Estimates
|
•
|
Volume, net of contractual price reductions—changes in volume offset by contractual price reductions (which typically range from 1% to 3% of net sales) and changes in mix;
|
•
|
Operational performance—changes to costs for materials and commodities or manufacturing and engineering variances; and
|
•
|
Other—including restructuring costs and any remaining variances not included in Volume, net of contractual price reductions or Operational performance.
|
|
Three Months Ended March 31,
|
||||||||||
|
2019
|
|
2018
|
|
Favorable/(unfavorable)
|
||||||
|
|
|
|
|
|
||||||
|
(dollars in millions)
|
||||||||||
Net sales
|
$
|
3,575
|
|
|
$
|
3,630
|
|
|
$
|
(55
|
)
|
Cost of sales
|
2,962
|
|
|
2,947
|
|
|
(15
|
)
|
|||
Gross margin
|
613
|
|
17.1%
|
683
|
|
18.8%
|
(70
|
)
|
|||
Selling, general and administrative
|
256
|
|
|
259
|
|
|
3
|
|
|||
Amortization
|
34
|
|
|
30
|
|
|
(4
|
)
|
|||
Restructuring
|
26
|
|
|
20
|
|
|
(6
|
)
|
|||
Operating income
|
297
|
|
|
374
|
|
|
(77
|
)
|
|||
Interest expense
|
(38
|
)
|
|
(34
|
)
|
|
(4
|
)
|
|||
Other income, net
|
16
|
|
|
30
|
|
|
(14
|
)
|
|||
Income before income taxes and equity income
|
275
|
|
|
370
|
|
|
(95
|
)
|
|||
Income tax expense
|
(33
|
)
|
|
(59
|
)
|
|
26
|
|
|||
Income before equity income
|
242
|
|
|
311
|
|
|
(69
|
)
|
|||
Equity income, net of tax
|
3
|
|
|
5
|
|
|
(2
|
)
|
|||
Net income
|
245
|
|
|
316
|
|
|
(71
|
)
|
|||
Net income attributable to noncontrolling interest
|
5
|
|
|
9
|
|
|
(4
|
)
|
|||
Net income attributable to Aptiv
|
$
|
240
|
|
|
$
|
307
|
|
|
$
|
(67
|
)
|
|
Three Months Ended March 31,
|
|
|
Variance Due To:
|
||||||||||||||||||||||||||||
|
2019
|
|
2018
|
|
Favorable/(unfavorable)
|
|
|
Volume, net of contractual price reductions
|
|
FX
|
|
Commodity pass-through
|
|
Other
|
|
Total
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
(in millions)
|
|
|
(in millions)
|
||||||||||||||||||||||||||||
Total net sales
|
$
|
3,575
|
|
|
$
|
3,630
|
|
|
$
|
(55
|
)
|
|
|
$
|
108
|
|
|
$
|
(148
|
)
|
|
$
|
(15
|
)
|
|
$
|
—
|
|
|
$
|
(55
|
)
|
|
Three Months Ended March 31,
|
|
|
Variance Due To:
|
||||||||||||||||||||||||||||
|
2019
|
|
2018
|
|
Favorable/(unfavorable)
|
|
|
Volume (a)
|
|
FX
|
|
Operational performance
|
|
Other
|
|
Total
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
(dollars in millions)
|
|
|
(in millions)
|
||||||||||||||||||||||||||||
Cost of sales
|
$
|
2,962
|
|
|
$
|
2,947
|
|
|
$
|
(15
|
)
|
|
|
$
|
(181
|
)
|
|
$
|
118
|
|
|
$
|
19
|
|
|
$
|
29
|
|
|
$
|
(15
|
)
|
Gross margin
|
$
|
613
|
|
|
$
|
683
|
|
|
$
|
(70
|
)
|
|
|
$
|
(73
|
)
|
|
$
|
(30
|
)
|
|
$
|
19
|
|
|
$
|
14
|
|
|
$
|
(70
|
)
|
Percentage of net sales
|
17.1
|
%
|
|
18.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Presented net of contractual price reductions for gross margin variance.
|
•
|
$15 million of decreased commodity costs; and
|
•
|
$3 million of decreased warranty costs.
|
|
Three Months Ended March 31,
|
||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
||||||
|
|
|
|
|
|
||||||
|
(dollars in millions)
|
||||||||||
Selling, general and administrative expense
|
$
|
256
|
|
|
$
|
259
|
|
|
$
|
3
|
|
Percentage of net sales
|
7.2
|
%
|
|
7.1
|
%
|
|
|
|
Three Months Ended March 31,
|
||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
||||||
|
|
|
|
|
|
||||||
|
(in millions)
|
||||||||||
Amortization
|
$
|
34
|
|
|
$
|
30
|
|
|
$
|
(4
|
)
|
|
Three Months Ended March 31,
|
||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
||||||
|
|
|
|
|
|
||||||
|
(dollars in millions)
|
||||||||||
Restructuring
|
$
|
26
|
|
|
$
|
20
|
|
|
$
|
(6
|
)
|
Percentage of net sales
|
0.7
|
%
|
|
0.6
|
%
|
|
|
|
Three Months Ended March 31,
|
||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
||||||
|
|
|
|
|
|
||||||
|
(in millions)
|
||||||||||
Interest expense
|
$
|
38
|
|
|
$
|
34
|
|
|
$
|
(4
|
)
|
|
Three Months Ended March 31,
|
||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
||||||
|
|
|
|
|
|
||||||
|
(in millions)
|
||||||||||
Other income, net
|
$
|
16
|
|
|
$
|
30
|
|
|
$
|
(14
|
)
|
|
Three Months Ended March 31,
|
||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
||||||
|
|
|
|
|
|
||||||
|
(in millions)
|
||||||||||
Income tax expense
|
$
|
33
|
|
|
$
|
59
|
|
|
$
|
26
|
|
|
Three Months Ended March 31,
|
||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
||||||
|
|
|
|
|
|
||||||
|
(in millions)
|
||||||||||
Equity income, net of tax
|
$
|
3
|
|
|
$
|
5
|
|
|
$
|
(2
|
)
|
•
|
Signal and Power Solutions, which includes complete electrical architecture and component products.
|
•
|
Advanced Safety and User Experience, which includes component and systems integration expertise in infotainment and connectivity, body controls and security systems, active and passive safety electronics, autonomous driving software and technologies, as well as advanced development of software.
|
•
|
Eliminations and Other, which includes i) the elimination of inter-segment transactions, and ii) certain other expenses and income of a non-operating or strategic nature.
|
|
Signal and Power Solutions
|
|
Advanced Safety and User Experience
|
|
Eliminations and Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
For the Three Months Ended March 31, 2019:
|
|
|
|
|
|
|
|
||||||||
Adjusted operating income
|
$
|
283
|
|
|
$
|
62
|
|
|
$
|
—
|
|
|
$
|
345
|
|
Restructuring
|
(19
|
)
|
|
(7
|
)
|
|
—
|
|
|
(26
|
)
|
||||
Other acquisition and portfolio project costs
|
(7
|
)
|
|
(4
|
)
|
|
—
|
|
|
(11
|
)
|
||||
Deferred compensation related to nuTonomy acquisition
|
—
|
|
|
(11
|
)
|
|
—
|
|
|
(11
|
)
|
||||
Operating income
|
$
|
257
|
|
|
$
|
40
|
|
|
$
|
—
|
|
|
297
|
|
|
Interest expense
|
|
|
|
|
|
|
(38
|
)
|
|||||||
Other income, net
|
|
|
|
|
|
|
16
|
|
|||||||
Income before income taxes and equity income
|
|
|
|
|
|
|
275
|
|
|||||||
Income tax expense
|
|
|
|
|
|
|
(33
|
)
|
|||||||
Equity income, net of tax
|
|
|
|
|
|
|
3
|
|
|||||||
Net income
|
|
|
|
|
|
|
245
|
|
|||||||
Net income attributable to noncontrolling interest
|
|
|
|
|
|
|
5
|
|
|||||||
Net income attributable to Aptiv
|
|
|
|
|
|
|
$
|
240
|
|
|
Signal and Power Solutions
|
|
Advanced Safety and User Experience
|
|
Eliminations and Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
|
(in millions)
|
||||||||||||||
For the Three Months Ended March 31, 2018:
|
|
|
|
|
|
|
|
||||||||
Adjusted operating income
|
$
|
351
|
|
|
$
|
76
|
|
|
$
|
—
|
|
|
$
|
427
|
|
Restructuring
|
(18
|
)
|
|
(2
|
)
|
|
—
|
|
|
(20
|
)
|
||||
Other acquisition and portfolio project costs
|
(11
|
)
|
|
(8
|
)
|
|
—
|
|
|
(19
|
)
|
||||
Deferred compensation related to nuTonomy acquisition
|
—
|
|
|
(14
|
)
|
|
—
|
|
|
(14
|
)
|
||||
Operating income
|
$
|
322
|
|
|
$
|
52
|
|
|
$
|
—
|
|
|
374
|
|
|
Interest expense
|
|
|
|
|
|
|
(34
|
)
|
|||||||
Other income, net
|
|
|
|
|
|
|
30
|
|
|||||||
Income before income taxes and equity income
|
|
|
|
|
|
|
370
|
|
|||||||
Income tax expense
|
|
|
|
|
|
|
(59
|
)
|
|||||||
Equity income, net of tax
|
|
|
|
|
|
|
5
|
|
|||||||
Net income
|
|
|
|
|
|
|
316
|
|
|||||||
Net income attributable to noncontrolling interest
|
|
|
|
|
|
|
9
|
|
|||||||
Net income attributable to Aptiv
|
|
|
|
|
|
|
$
|
307
|
|
|
Three Months Ended March 31,
|
|
|
Variance Due To:
|
||||||||||||||||||||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
|
|
Volume, net of contractual price reductions
|
|
FX
|
|
Commodity pass-through
|
|
Other
|
|
Total
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
(in millions)
|
|
|
(in millions)
|
||||||||||||||||||||||||||||
Signal and Power Solutions
|
$
|
2,562
|
|
|
$
|
2,617
|
|
|
$
|
(55
|
)
|
|
|
$
|
71
|
|
|
$
|
(111
|
)
|
|
$
|
(15
|
)
|
|
$
|
—
|
|
|
$
|
(55
|
)
|
Advanced Safety and User Experience
|
1,023
|
|
|
1,032
|
|
|
(9
|
)
|
|
|
29
|
|
|
(38
|
)
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
||||||||
Eliminations and Other
|
(10
|
)
|
|
(19
|
)
|
|
9
|
|
|
|
8
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
9
|
|
||||||||
Total
|
$
|
3,575
|
|
|
$
|
3,630
|
|
|
$
|
(55
|
)
|
|
|
$
|
108
|
|
|
$
|
(148
|
)
|
|
$
|
(15
|
)
|
|
$
|
—
|
|
|
$
|
(55
|
)
|
|
Three Months Ended March 31,
|
||||
|
2019
|
|
2018
|
||
Signal and Power Solutions
|
19.5
|
%
|
|
21.4
|
%
|
Advanced Safety and User Experience
|
11.1
|
%
|
|
12.0
|
%
|
Eliminations and Other
|
—
|
%
|
|
—
|
%
|
Total
|
17.1
|
%
|
|
18.8
|
%
|
|
Three Months Ended March 31,
|
|
|
Variance Due To:
|
||||||||||||||||||||||||
|
2019
|
|
2018
|
|
Favorable/
(unfavorable)
|
|
|
Volume, net of contractual price reductions
|
|
Operational performance
|
|
Other
|
|
Total
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
(in millions)
|
|
|
(in millions)
|
||||||||||||||||||||||||
Signal and Power Solutions
|
$
|
283
|
|
|
$
|
351
|
|
|
$
|
(68
|
)
|
|
|
$
|
(59
|
)
|
|
$
|
4
|
|
|
$
|
(13
|
)
|
|
$
|
(68
|
)
|
Advanced Safety and User Experience
|
62
|
|
|
76
|
|
|
(14
|
)
|
|
|
(14
|
)
|
|
12
|
|
|
(12
|
)
|
|
(14
|
)
|
|||||||
Eliminations and Other
|
—
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Total
|
$
|
345
|
|
|
$
|
427
|
|
|
$
|
(82
|
)
|
|
|
$
|
(73
|
)
|
|
$
|
16
|
|
|
$
|
(25
|
)
|
|
$
|
(82
|
)
|
•
|
Unfavorable foreign currency impacts of $20 million, primarily related to the Euro and Chinese Yuan Renminbi; and
|
•
|
$18 million of increased depreciation and amortization, primarily as a result of a higher fixed asset base; partially offset by
|
•
|
$3 million of decreased warranty costs.
|
|
March 31,
2019 |
||
|
|
||
|
(in millions)
|
||
Cash and cash equivalents
|
$
|
321
|
|
Revolving Credit Facility, unutilized portion (1)
|
1,825
|
|
|
Committed European accounts receivable factoring facility, unutilized portion (2)
|
2
|
|
|
Total available liquidity
|
$
|
2,148
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Total number of shares repurchased
|
2,840,079
|
|
|
1,676,144
|
|
||
Average price paid per share
|
$
|
79.57
|
|
|
$
|
89.17
|
|
Total (in millions)
|
$
|
226
|
|
|
$
|
149
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||||||
|
LIBOR plus
|
|
ABR plus
|
|
LIBOR plus
|
|
ABR plus
|
||||
Revolving Credit Facility
|
1.10
|
%
|
|
0.10
|
%
|
|
1.10
|
%
|
|
0.10
|
%
|
Tranche A Term Loan
|
1.25
|
%
|
|
0.25
|
%
|
|
1.25
|
%
|
|
0.25
|
%
|
|
|
|
Borrowings as of
|
|
|
|||
|
|
|
March 31, 2019
|
|
Rates effective as of
|
|||
|
Applicable Rate
|
|
(in millions)
|
|
March 31, 2019
|
|||
Revolving Credit Facility
|
ABR plus 0.10%
|
|
$
|
25
|
|
|
5.60
|
%
|
Revolving Credit Facility
|
LIBOR plus 1.10%
|
|
$
|
150
|
|
|
3.60
|
%
|
Tranche A Term Loan
|
LIBOR plus 1.25%
|
|
$
|
380
|
|
|
3.75
|
%
|
Period
|
|
Total Number of Shares Purchased (1)
|
|
Average Price Paid per Share (2)
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares that May Yet be Purchased Under the Program (in millions) (3)
|
||||||
January 1, 2019 to January 31, 2019
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
2,490
|
|
February 1, 2019 to February 28, 2019
|
|
2,406,149
|
|
|
78.96
|
|
|
2,406,149
|
|
|
2,300
|
|
||
March 1, 2019 to March 31, 2019
|
|
433,930
|
|
|
82.92
|
|
|
433,930
|
|
|
2,264
|
|
||
Total
|
|
2,840,079
|
|
|
79.57
|
|
|
2,840,079
|
|
|
|
(1)
|
The total number of shares purchased under the plans authorized by the Board of Directors are described below.
|
(2)
|
Excluding commissions.
|
(3)
|
In January 2019, the Board of Directors authorized a share repurchase program of up to $2.0 billion. This program will commence following the completion of the previously announced share repurchase program of $1.5 billion, which was approved by the Board of Directors in April 2016. The timing of repurchases is dependent on price, market conditions and applicable regulatory requirements.
|
Exhibit
Number
|
|
Description
|
10.1
|
|
|
10.2
|
|
|
31.1
|
|
|
31.2
|
|
|
32.1
|
|
|
32.2
|
|
|
101.INS
|
|
XBRL Instance Document# - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document#
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document#
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document#
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document#
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document#
|
|
|
|
|
|
APTIV PLC
|
|
|
|
|
|
/s/ Joseph R. Massaro
|
|
|
By: Joseph R. Massaro
|
|
|
Senior Vice President and
|
|
|
Chief Financial Officer
|
1.
|
Title: [Title]
|
2.
|
Legal Employer: [Legal Entity]
|
3.
|
Principal Place of Employment: [Primary Employment Location]
|
4.
|
Allocation of Work Time: Aptiv anticipates that approximately [#] working days per year will be spent working on Company business for OpCo, of which approximately [#] days will be spent working in Dublin, Ireland, with the rest spent at other global locations. Any remaining days will be spent providing services to TechCo while working for Aptiv Services General Partnership (hereafter “AUSS GP”).
|
5.
|
Compensation: Your total annual compensation (including base salary, annual incentive, and long-term incentive) will remain unchanged from the compensation approved by [approval body] of Aptiv. You will remain on the U.S. payroll, and will continue to be paid in U.S. dollars, subject to applicable deductions and withholdings made by your payroll administrator.
|
6.
|
Allocation of Compensation:
|
•
|
Allocation of Salary: [$] of your annual base salary, subject to any Irish statutory withholding obligations required.
|
•
|
Allocation of Annual Incentive Plan (AIP) Awards: [$] of your AIP individual target will be allocated to OpCo, subject any Irish statutory withholding obligations required.
|
•
|
Subject to Change: The allocation of compensation between services provided for the benefit of OpCo and the services provided to TechCo while working for AUSS GP is subject to change based on future changes in responsibilities and/or compensation.
|
7.
|
Benefits: You will remain eligible for all employee benefit plans offered to the Company’s U.S. employees (including but not necessarily limited to the Salaried Health Care Program, the Salaried Life & Disability Benefits Program, the Salaried Retirement Savings Program, and the Salaried Retirement Equalization Savings Program). Unless otherwise legally required, you will not be eligible to receive any Irish benefits.
|
8.
|
Board Membership: To the extent you sit on the board of an Irish group company, you are not eligible to receive any compensation in respect of your role as a board member.
|
9.
|
Travel & Expenses: As your base of employment will be [Primary Employment Location], all expenses relating to travel (airfare, lodging, meals, etc.) to other locations will be processed in accordance with the Company’s travel and expense policy.
|
10.
|
Income Tax:
|
•
|
U.S. Income Tax: U.S. federal income taxes will be withheld from your paycheck
|
•
|
Ireland Income Tax: Your allocated income will be subject to tax in Ireland based on the number of days you work in Ireland. Irish income tax will be collected through an Irish payroll. Income taxes due to Ireland will result in a reduction of amounts withheld for U.S. federal income taxes through US payroll. You are responsible for any Irish tax liabilities that arise from working in Ireland, however, if working in Ireland results in additional incremental tax, the Company will provide tax equalization (including gross-up) pursuant to the Company’s current tax equalization policy.
|
•
|
Tax Preparation: You may choose to retain a tax preparer (at your expense) to prepare your U.S. and/or Ireland tax returns; however, all tax returns must be reviewed by the Company’s selected vendor prior to filing. If you prefer, you have the option of receiving tax preparation services for the U.S. and/or Ireland tax returns from a vendor selected and paid for by Aptiv (the cost of such tax preparation services would be imputed income to you, and would not be grossed up). Should tax equalization be required, the tax vendor designated by Aptiv will prepare the calculation at Aptiv’s expense.
|
•
|
Tax Audits: Should you be subject to an income tax audit during which an issue related to this allocation is raised by either U.S. or Ireland authorities, the Company agrees to provide full support for the audit, even if you are no longer employed by the Company at the time of the audit. Likewise, you agree to provide any relevant information to the Company if needed to aid conclusion of any relevant portion of a tax audit.
|
11.
|
Governing Law: This letter will be construed in accordance with and governed by the laws of the State of Michigan, without regard to the choice of law principles thereof. Any suit, action or other legal proceeding arising out of or relating to this letter shall be brought exclusively in the federal or state courts located in the State of Michigan.
|
1.
|
PURPOSE OF THE PLAN
|
2.
|
EFFECTIVE DATE AND DURATION OF THE PLAN
|
3.
|
PLAN ADMINISTRATION AND ELIGIBILITY
|
(a)
|
The Plan shall be administered by the Compensation and Human Resources Committee (the “Committee”) of the Aptiv Board of Directors (the “Board”). The Committee may authorize target award grants to employees. The Committee, in its sole discretion, shall determine the performance period, the performance levels at which different percentages of such awards will be earned, the collective amount for all awards to be granted at any one time, whether and to what extent awards are settled in cash, ordinary shares of Aptiv, or a combination thereof, and the individual grants with respect to employees who are officers of Aptiv. The Committee may delegate to the Chief Executive Officer, the officers or such other committee or individual as determined by the Committee responsibility for determining, within the limits established by the Committee, individual award grants for employees who are not officers. All awards granted under the Plan will be denominated in cash (U.S. dollars or local currency equivalent). All awards granted under the Plan shall be paid in cash, unrestricted or restricted ordinary shares of Aptiv (which will be provided under a shareholder-approved equity plan of Aptiv, subject to the terms and conditions of such plan), or a combination of the foregoing, as determined by the Committee.
|
(b)
|
The Committee shall have full power and authority to construe and interpret the Plan. The Committee shall determine the selection of employees for participation in the Plan and also decide any questions and settle any disputes or controversies that may arise with respect to the Plan. Any person who accepts any award hereunder agrees to accept as final, conclusive, and binding all determinations of the Committee and the Aptiv officers. The Committee has the right, in the case of participants not employed in the United States, to vary from the provisions of the Plan in order to preserve its incentive features.
|
(c)
|
Only persons who are employees of Aptiv are eligible to receive an award under the Plan. Subject to such additional limitations or restrictions as the Committee may impose, the term “employees” means persons (i) who are employed by Aptiv, or any subsidiary (as defined below), including employees who are also directors of Aptiv or any such subsidiary, or (ii) who accept (or previously have accepted) employment, at
|
4.
|
DETERMINATION OF ANNUAL INCENTIVE AWARD
|
(a)
|
Prior to the grant of any target award, the Committee will establish performance levels for each such award related to Aptiv and its affiliates at which 100% of the award will be earned and a range (which need not be the same for all awards) within which greater and lesser percentages will be earned. The “performance period” will be twelve (12) months or less.
|
(b)
|
With respect to the performance levels to be established, the Committee will establish the specific measures for each grant at the time of such grant. In creating these measures, the Committee may establish the specific goals based upon or relating to one or more specified criteria. If the Committee determines that a change in the business, operations, corporate structure or capital structure of Aptiv, or the manner in which Aptiv conducts its business, or other events or circumstances render the performance objectives unsuitable, the Committee may modify the performance objectives or the related minimum acceptable level of achievement, in whole or in part, as the Committee deems appropriate and equitable. Performance measures may vary from award to award, and from participant to participant, and may be established on a stand-alone basis, in tandem or in the alternative.
|
(c)
|
No target award will be granted to any director of Aptiv who is not an employee at the date of grant.
|
(d)
|
If an employee is promoted during the performance period, a target award may be increased to reflect such employee’s new responsibilities.
|
(e)
|
The Committee may adjust the performance levels and goals for any performance period and shall have the authority to make appropriate adjustments as it deems equitable in recognition of unusual or non-recurring events affecting Aptiv, changes in applicable tax laws or accounting principles, or such other factors as the Committee may determine to preserve the incentive features of the Plan (including, without limitation, any adjustments that would result in Aptiv paying non-deductible compensation to a participant).
|
5.
|
DETERMINATION AND PAYMENT OF FINAL AWARD
|
(a)
|
Except as otherwise provided in the Plan, the percentage of each target award to be distributed to an employee will be determined by the Committee on the basis of the performance levels established for such award and the performance of the applicable enterprise or specified portion thereof, as the case may be, during the performance period. Following determination of the final payout percentage, the Committee may, including upon the recommendation of the Chief Executive Officer (for all participants other than the Chief Executive Officer), make adjustments to awards (including adjustments that result in an employee receiving no payout) for officers to reflect individual performance or any other business factor during such
|
(b)
|
Payment of any final award (or portion thereof) to an employee is subject to the satisfaction of the conditions precedent that such employee: (i) continue to render services as an employee through the end of the performance period, unless waived by the Committee, (ii) refrain from engaging in any activity through the end of the performance period which, in the opinion of the Committee, is competitive with any activity of Aptiv or any subsidiary (except that employment at the request of Aptiv with an entity in which Aptiv has, directly or indirectly, a substantial ownership interest, or other employment specifically approved by the Committee, may not be considered to be an activity which is competitive with any activity of Aptiv or any subsidiary) and from otherwise acting, either prior to or after termination of employment, in any manner inimical or in any way contrary to the best interests of Aptiv, and (iii) furnish to Aptiv such information with respect to the satisfaction of the foregoing conditions precedent as the Committee may reasonably request.
|
(c)
|
Final awards shall vest at the end of the performance period and shall be paid as soon as practicable following the end of the applicable performance period, but in no event later than March 15 following the last day of the applicable performance period unless the Committee, in its sole discretion, provides for the deferral of a payout under a nonqualified deferred compensation plan or program maintained by Aptiv, subject to the terms and conditions of such plan or program.
|
6.
|
TREATMENT OF AWARDS UPON EMPLOYEE’S DEATH OR TERMINATION OF EMPLOYMENT
|
(a)
|
If an employee (i) is terminated for Cause at any time during the performance period, (ii) is terminated without Cause during the performance period but prior to having been employed for six months during the performance period, or (iii) voluntarily quits employment (not due to Retirement) at any time during the performance period, except as otherwise determined by the Committee, no award will be paid to the employee.
|
(b)
|
If, upon death or a Qualified Termination of an employee’s employment prior to the end of any performance period, other than an involuntary termination without Cause prior to having been employed for six months during the performance period, the Committee determines to waive the condition precedent of continuing to render services as provided in paragraph 5(b), then the target award granted to such employee with respect to such performance period will be reduced pro rata based on the number of days remaining in the performance period after the month of death or termination, and is subject to further adjustment (including adjustments that result in an employee receiving no payout) to reflect individual performance or any other business factor; provided further that such actions would not cause any payment to result in deferred compensation that is subject to the additional tax under Section 409A of the Code. The final award for such employee will be determined by the Committee, including upon the recommendation of the Chief Executive Officer (for all participants other than the Chief Executive Officer), (i) on the basis of the performance levels established for such award (including the minimum performance level) and the performance level achieved through the end of the performance period and (ii) in the discretion of the Committee, on the basis of individual performance or any other business factor during the period prior to death or termination, and will be paid in accordance with paragraph 5(c).
|
7.
|
CHANGE IN CONTROL
|
(a)
|
Upon the effective date of a Change in Control, all outstanding unvested awards granted under this Plan will vest on a pro rata basis based on the greater of target award or actual performance during the applicable performance period up to the date of the Change in Control. The pro-rated award shall be paid as a single lump sum payment as soon as reasonably practicable following the date of the Change in Control, but in no event later than March 15 of the calendar year following the year in which the Change in Control occurs.
|
(b)
|
The term “Change in Control” means the occurrence of any one or more of the following events:
|
8.
|
PLAN AMENDMENT, MODIFICATION, SUSPENSION OR TERMINATION
|
9.
|
GOVERNING LAW
|
10.
|
MISCELLANEOUS
|
(a)
|
No employee, participant or other person shall have any claim to be granted any award under the Plan, and there is no obligation for uniformity of treatment of employees, participants or holders or beneficiaries of awards under the Plan. The grant of an award under the Plan shall not be construed as giving an employee the right to be retained in the employ of, or to continue to provide services to, Aptiv or any subsidiary. Further, Aptiv or the applicable subsidiary may at any time dismiss an employee, free from any liability, or any claim under the Plan, unless otherwise expressly provided in the Plan.
|
(b)
|
All final awards which have been awarded in accordance with the provisions of the Plan will be paid as soon as practicable following the end of the related performance period but prior to March 15 of the following year. If Aptiv has any unpaid claim against an employee arising out of or in connection with the employee’s employment with Aptiv, such claim may be offset against awards under the Plan. Such claim may include, but is not limited to, unpaid taxes or corporate business credit card charges.
|
(c)
|
All payments and distributions will be paid from the general assets of Aptiv. Nothing contained in the Plan, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between Aptiv and any employee, former employee, or any other person.
|
(d)
|
The expenses of administering this Plan will be borne by Aptiv.
|
(e)
|
Except as otherwise determined by the Committee, with the exception of transfer by will or the laws of descent and distribution, no target or final award is assignable or transferable and, during the lifetime of the employee, any payment of any final award will only be made to the employee.
|
(f)
|
In the event of death, the executor(s) or administrator(s) of the employee’s estate, or such other person(s) as determined by a court of competent jurisdiction, may receive payment, in accordance with and subject to the provisions of this Plan, provided the executor(s), administrator(s), or other person supplies documentation satisfactory to Aptiv to so act. Upon making such determination, Aptiv is relieved of any further liability regarding any award to the deceased employee.
|
(g)
|
If Aptiv is required to prepare an accounting restatement due to the material noncompliance of Aptiv, as a result of misconduct, with any financial reporting requirement under the securities laws, and if the participant knowingly or grossly negligently engaged in the misconduct, or knowingly or grossly negligently failed to prevent the misconduct, or if the participant is one of the individuals subject to automatic forfeiture under Section 304 of the United States Sarbanes-Oxley Act of 2002 (and not otherwise exempted), the participant shall reimburse Aptiv the amount of any payment in settlement of any award under the Plan earned or accrued during the twelve-month period following the first public issuance or filing with the United States Securities and Exchange Commission (whichever first occurred) of the financial document not in compliance with such financial reporting requirement. Rights, payments and benefits under any award under the Plan shall be subject to repayment to or recoupment (clawback) by Aptiv in accordance with such policies and procedures as the Committee or Board may adopt from time to time, including policies and procedures to implement applicable law, stock market or exchange rules and regulations or accounting or tax rules and regulations.
|
(h)
|
Aptiv shall be authorized to withhold from any payment due or transfer made under any award under the Plan or from any compensation or other amount owing to a participant the amount (in cash, ordinary shares of Aptiv, other awards, other property, net settlement or any combination thereof) of applicable withholding taxes due in respect of an award, its exercise or settlement or any payment or transfer under such award or under the Plan and to take such other action (including providing for elective payment of such amounts in cash or ordinary shares of Aptiv by the participant) as may be necessary in the opinion of Aptiv to satisfy all obligations for the payment of such taxes.
|
(i)
|
With respect to awards subject to Section 409A of the Code, the Plan is intended to comply with the requirements of Section 409A of the Code, and the provisions of the Plan shall be interpreted in a manner that satisfies the requirements of Section 409A of the Code, and the Plan shall be operated accordingly. If any provision of the Plan or any term or condition of any award would otherwise frustrate or conflict with this intent, the provision, term or condition will be interpreted and deemed amended so as to avoid this conflict. If an amount payable under an award as a result of the participant’s termination of employment (other than due to death) occurring while the participant is a “specified employee” under Section 409A of the Code constitutes a deferral of compensation subject to Section 409A of the Code, then payment of such amount shall not occur until six months and one day after the date of the participant’s termination of employment, except as permitted under Section 409A of the Code. If an award includes a “series of installment payments” (within the meaning of Section 1.409A-2(b)(2)(iii) of the Treasury Regulations), the participant’s right to the series of installment payments shall be treated as a right to a series of separate payments and not as a right to a single payment. Notwithstanding the foregoing, the tax treatment of the benefits provided under the Plan is not warranted or guaranteed, and in no event shall Aptiv be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the participant on account of non-compliance with Section 409A of the Code.
|
(j)
|
By participating in the Plan, the participant consents to the holding and processing of personal information provided by the participant to Aptiv or any subsidiary, trustee or third party service provider, for all purposes relating to the operation of the Plan. These include, but are not limited to: (i) administering and maintaining participant records; (ii) providing information to Aptiv, subsidiaries, trustees of any employee benefit trust, registrars, brokers or third party administrators of the Plan; (iii) providing information to future purchasers or merger partners of Aptiv or any subsidiary, or the business in which the participant works; and (iv) transferring information about the participant to any country or territory that may not provide the same protection for the information as the participant’s home country.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Aptiv PLC;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
/s/ Kevin P. Clark
|
|
Kevin P. Clark
|
|
President and Chief Executive Officer
|
|
(Principal Executive Officer)
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Aptiv PLC;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
/s/ Joseph R. Massaro
|
|
Joseph R. Massaro
|
|
Senior Vice President and Chief Financial Officer
|
|
(Principal Financial Officer)
|
1.
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Kevin P. Clark
|
|
Kevin P. Clark
|
|
President and Chief Executive Officer
|
|
(Principal Executive Officer)
|
1.
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Joseph R. Massaro
|
|
Joseph R. Massaro
|
|
Senior Vice President and Chief Financial Officer
|
|
(Principal Financial Officer)
|